ZA200404310B - Avermectin B1 derivatives having an aminosulfonyloxy substituent in the 4"-position. - Google Patents
Avermectin B1 derivatives having an aminosulfonyloxy substituent in the 4"-position. Download PDFInfo
- Publication number
- ZA200404310B ZA200404310B ZA200404310A ZA200404310A ZA200404310B ZA 200404310 B ZA200404310 B ZA 200404310B ZA 200404310 A ZA200404310 A ZA 200404310A ZA 200404310 A ZA200404310 A ZA 200404310A ZA 200404310 B ZA200404310 B ZA 200404310B
- Authority
- ZA
- South Africa
- Prior art keywords
- phenyl
- substituted
- formula
- unsubstituted
- mono
- Prior art date
Links
- -1 aminosulfonyloxy substituent Chemical group 0.000 title claims description 104
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical class O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims description 136
- 239000000203 mixture Substances 0.000 claims description 75
- 239000004480 active ingredient Substances 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 38
- 238000002360 preparation method Methods 0.000 claims description 35
- 229910052736 halogen Inorganic materials 0.000 claims description 31
- 150000002367 halogens Chemical class 0.000 claims description 30
- 241000607479 Yersinia pestis Species 0.000 claims description 23
- 229910052799 carbon Inorganic materials 0.000 claims description 18
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 17
- 150000003839 salts Chemical group 0.000 claims description 17
- 125000001424 substituent group Chemical group 0.000 claims description 17
- 239000002671 adjuvant Substances 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
- 125000000623 heterocyclic group Chemical group 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 125000004104 aryloxy group Chemical group 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000004450 alkenylene group Chemical group 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 6
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 6
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
- 230000000361 pesticidal effect Effects 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 51
- 239000000243 solution Substances 0.000 description 41
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 40
- 239000005660 Abamectin Substances 0.000 description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 33
- 241000196324 Embryophyta Species 0.000 description 31
- 239000000047 product Substances 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 239000002904 solvent Substances 0.000 description 17
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 229910052794 bromium Inorganic materials 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 15
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 14
- 239000000460 chlorine Substances 0.000 description 14
- 238000001704 evaporation Methods 0.000 description 14
- 230000008020 evaporation Effects 0.000 description 14
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 230000014759 maintenance of location Effects 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 238000005481 NMR spectroscopy Methods 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 229910052801 chlorine Inorganic materials 0.000 description 11
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 239000011737 fluorine Substances 0.000 description 10
- 229910052731 fluorine Inorganic materials 0.000 description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 9
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 239000000741 silica gel Substances 0.000 description 9
- 229910002027 silica gel Inorganic materials 0.000 description 9
- 239000007858 starting material Substances 0.000 description 9
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000000654 additive Substances 0.000 description 8
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical class C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- 229940093956 potassium carbonate Drugs 0.000 description 8
- 125000006239 protecting group Chemical group 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 7
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 7
- 238000004440 column chromatography Methods 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 229940113088 dimethylacetamide Drugs 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 240000001307 Myosotis scorpioides Species 0.000 description 6
- 241000244206 Nematoda Species 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 239000004495 emulsifiable concentrate Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- 239000005995 Aluminium silicate Substances 0.000 description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 5
- 235000012211 aluminium silicate Nutrition 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 150000002431 hydrogen Chemical class 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 241000256250 Spodoptera littoralis Species 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 229910052786 argon Inorganic materials 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 4
- 238000003818 flash chromatography Methods 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 235000009973 maize Nutrition 0.000 description 4
- 229940098779 methanesulfonic acid Drugs 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- GRJJQCWNZGRKAU-UHFFFAOYSA-N pyridin-1-ium;fluoride Chemical compound F.C1=CC=NC=C1 GRJJQCWNZGRKAU-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- QAHVHSLSRLSVGS-UHFFFAOYSA-N sulfamoyl chloride Chemical compound NS(Cl)(=O)=O QAHVHSLSRLSVGS-UHFFFAOYSA-N 0.000 description 4
- 239000004546 suspension concentrate Substances 0.000 description 4
- 125000000335 thiazolyl group Chemical group 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 241000238876 Acari Species 0.000 description 3
- 240000007124 Brassica oleracea Species 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 230000000895 acaricidal effect Effects 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 3
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 description 3
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Chemical compound C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 125000002541 furyl group Chemical group 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 125000001188 haloalkyl group Chemical group 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- UJJUEJRWNWVHCM-UHFFFAOYSA-N n-methylsulfamoyl chloride Chemical compound CNS(Cl)(=O)=O UJJUEJRWNWVHCM-UHFFFAOYSA-N 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 229920005552 sodium lignosulfonate Polymers 0.000 description 3
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- 125000005270 trialkylamine group Chemical group 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- KAATUXNTWXVJKI-NSHGMRRFSA-N (1R)-cis-(alphaS)-cypermethrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-NSHGMRRFSA-N 0.000 description 2
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 description 2
- KKZUMAMOMRDVKA-UHFFFAOYSA-N 2-chloropropane Chemical group [CH2]C(C)Cl KKZUMAMOMRDVKA-UHFFFAOYSA-N 0.000 description 2
- BQMRHYBXRAYYQS-UHFFFAOYSA-N 4-dihydroxyphosphinothioyloxy-n,n-diethyl-6-methylpyrimidin-2-amine Chemical compound CCN(CC)C1=NC(C)=CC(OP(O)(O)=S)=N1 BQMRHYBXRAYYQS-UHFFFAOYSA-N 0.000 description 2
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 2
- 239000005877 Alpha-Cypermethrin Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193388 Bacillus thuringiensis Species 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- 239000005884 Beta-Cyfluthrin Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 239000005946 Cypermethrin Substances 0.000 description 2
- 241001529600 Diabrotica balteata Species 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000005899 Fipronil Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 241000256244 Heliothis virescens Species 0.000 description 2
- 241001480224 Heterodera Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- 241001143352 Meloidogyne Species 0.000 description 2
- 241000243786 Meloidogyne incognita Species 0.000 description 2
- 241000243785 Meloidogyne javanica Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical class CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 241000193943 Pratylenchus Species 0.000 description 2
- 241001468227 Streptomyces avermitilis Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000005937 Tebufenozide Substances 0.000 description 2
- 241001454293 Tetranychus urticae Species 0.000 description 2
- QQODLKZGRKWIFG-RUTXASTPSA-N [(R)-cyano-(4-fluoro-3-phenoxyphenyl)methyl] (1S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-RUTXASTPSA-N 0.000 description 2
- 239000000642 acaricide Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- KXRPCFINVWWFHQ-UHFFFAOYSA-N cadusafos Chemical compound CCC(C)SP(=O)(OCC)SC(C)CC KXRPCFINVWWFHQ-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000007931 coated granule Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 2
- 229960005424 cypermethrin Drugs 0.000 description 2
- GCKZANITAMOIAR-XWVCPFKXSA-N dsstox_cid_14566 Chemical compound [O-]C(=O)C1=CC=CC=C1.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H]([NH2+]C)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 GCKZANITAMOIAR-XWVCPFKXSA-N 0.000 description 2
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 2
- 229940093476 ethylene glycol Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229940013764 fipronil Drugs 0.000 description 2
- 125000004438 haloalkoxy group Chemical group 0.000 description 2
- 125000004995 haloalkylthio group Chemical group 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000005910 lambda-Cyhalothrin Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- RMIODHQZRUFFFF-UHFFFAOYSA-N methoxyacetic acid Chemical class COCC(O)=O RMIODHQZRUFFFF-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000005645 nematicide Substances 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 2
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical class OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 2
- XLNZEKHULJKQBA-UHFFFAOYSA-N terbufos Chemical compound CCOP(=S)(OCC)SCSC(C)(C)C XLNZEKHULJKQBA-UHFFFAOYSA-N 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- NKNFWVNSBIXGLL-UHFFFAOYSA-N triazamate Chemical compound CCOC(=O)CSC1=NC(C(C)(C)C)=NN1C(=O)N(C)C NKNFWVNSBIXGLL-UHFFFAOYSA-N 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- OTLLEIBWKHEHGU-TUNUFRSWSA-N (2R,3S,4S,5S)-2-[(2R,3R,4R,5S,6R)-5-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)O[C@@H]1[C@@H](CO)O[C@H](O[C@H]([C@H](O)[C@H](OP(O)(O)=O)[C@H](O)C(O)=O)C(O)=O)[C@H](O)[C@H]1O OTLLEIBWKHEHGU-TUNUFRSWSA-N 0.000 description 1
- FSJYRLHKLVGCNH-UHFFFAOYSA-N (3-tert-butylphenyl) n-methylcarbamate Chemical compound CNC(=O)OC1=CC=CC(C(C)(C)C)=C1 FSJYRLHKLVGCNH-UHFFFAOYSA-N 0.000 description 1
- XUNYDVLIZWUPAW-UHFFFAOYSA-N (4-chlorophenyl) n-(4-methylphenyl)sulfonylcarbamate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)OC1=CC=C(Cl)C=C1 XUNYDVLIZWUPAW-UHFFFAOYSA-N 0.000 description 1
- YSEUOPNOQRVVDY-OGEJUEGTSA-N (5-benzylfuran-3-yl)methyl (1r,3r)-3-[(e)-3-methoxy-2-methyl-3-oxoprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 YSEUOPNOQRVVDY-OGEJUEGTSA-N 0.000 description 1
- VEMKTZHHVJILDY-WOJBJXKFSA-N (5-benzylfuran-3-yl)methyl (1s,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-WOJBJXKFSA-N 0.000 description 1
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 description 1
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 1
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 1
- FZRBKIRIBLNOAM-UHFFFAOYSA-N (E,E)-2-propynyl 3,7,11-trimethyl-2,4-dodecadienoate Chemical compound CC(C)CCCC(C)CC=CC(C)=CC(=O)OCC#C FZRBKIRIBLNOAM-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- XGWIJUOSCAQSSV-XHDPSFHLSA-N (S,S)-hexythiazox Chemical compound S([C@H]([C@@H]1C)C=2C=CC(Cl)=CC=2)C(=O)N1C(=O)NC1CCCCC1 XGWIJUOSCAQSSV-XHDPSFHLSA-N 0.000 description 1
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 description 1
- PCKNFPQPGUWFHO-SXBRIOAWSA-N (Z)-flucycloxuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1)=CC=C1CO\N=C(C=1C=CC(Cl)=CC=1)\C1CC1 PCKNFPQPGUWFHO-SXBRIOAWSA-N 0.000 description 1
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- 125000004530 1,2,4-triazinyl group Chemical group N1=NC(=NC=C1)* 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- RURQAJURNPMSSK-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3-{[2-(4-ethoxyphenyl)-3,3,3-trifluoropropoxy]methyl}benzene Chemical compound C1=CC(OCC)=CC=C1C(C(F)(F)F)COCC1=CC=CC(OC=2C=CC(Cl)=CC=2)=C1 RURQAJURNPMSSK-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- KPNPDRFFWQBXGT-UHFFFAOYSA-N 1-dimethoxyphosphorylsulfanyl-2-ethylsulfanylethane;2-ethylsulfanylethoxy-dimethoxy-sulfanylidene-$l^{5}-phosphane Chemical compound CCSCCOP(=S)(OC)OC.CCSCCSP(=O)(OC)OC KPNPDRFFWQBXGT-UHFFFAOYSA-N 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
- 125000001917 2,4-dinitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1*)[N+]([O-])=O)[N+]([O-])=O 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- BOTNFCTYKJBUMU-UHFFFAOYSA-N 2-[4-(2-methylpropyl)piperazin-4-ium-1-yl]-2-oxoacetate Chemical compound CC(C)C[NH+]1CCN(C(=O)C([O-])=O)CC1 BOTNFCTYKJBUMU-UHFFFAOYSA-N 0.000 description 1
- REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- ULOIAOPTGWSNHU-UHFFFAOYSA-N 2-butyl radical Chemical compound C[CH]CC ULOIAOPTGWSNHU-UHFFFAOYSA-N 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- ZDOOQPFIGYHZFV-UHFFFAOYSA-N 2-ethyl-4-[(4-phenoxyphenoxy)methyl]-1,3-dioxolane Chemical compound O1C(CC)OCC1COC(C=C1)=CC=C1OC1=CC=CC=C1 ZDOOQPFIGYHZFV-UHFFFAOYSA-N 0.000 description 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
- AUQAUAIUNJIIEP-UHFFFAOYSA-N 3,4,5-trimethylphenyl methylcarbamate Chemical compound CNC(=O)OC1=CC(C)=C(C)C(C)=C1 AUQAUAIUNJIIEP-UHFFFAOYSA-N 0.000 description 1
- PKTIFYGCWCQRSX-UHFFFAOYSA-N 4,6-diamino-2-(cyclopropylamino)pyrimidine-5-carbonitrile Chemical compound NC1=C(C#N)C(N)=NC(NC2CC2)=N1 PKTIFYGCWCQRSX-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- 125000004863 4-trifluoromethoxyphenyl group Chemical group [H]C1=C([H])C(OC(F)(F)F)=C([H])C([H])=C1* 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- 239000005875 Acetamiprid Substances 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000005652 Acrinathrin Substances 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 241000380490 Anguina Species 0.000 description 1
- 235000003276 Apios tuberosa Nutrition 0.000 description 1
- 101100446452 Arabidopsis thaliana FD2 gene Proteins 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010744 Arachis villosulicarpa Nutrition 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 239000005653 Bifenazate Substances 0.000 description 1
- 239000005874 Bifenthrin Substances 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- NYQDCVLCJXRDSK-UHFFFAOYSA-N Bromofos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(Br)C=C1Cl NYQDCVLCJXRDSK-UHFFFAOYSA-N 0.000 description 1
- MYTVVMGUDBRCDJ-UHFFFAOYSA-N Bufencarb Chemical compound CCCC(C)C1=CC=CC(OC(=O)NC)=C1.CCC(CC)C1=CC=CC(OC(=O)NC)=C1 MYTVVMGUDBRCDJ-UHFFFAOYSA-N 0.000 description 1
- 239000005885 Buprofezin Substances 0.000 description 1
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 description 1
- 125000006414 CCl Chemical group ClC* 0.000 description 1
- HNUALPPJLMYHDK-UHFFFAOYSA-N C[CH]C Chemical compound C[CH]C HNUALPPJLMYHDK-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEDTXTNSFWUXGQ-UHFFFAOYSA-N Carbophenothion Chemical compound CCOP(=S)(OCC)SCSC1=CC=C(Cl)C=C1 VEDTXTNSFWUXGQ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
- 239000005944 Chlorpyrifos Substances 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 239000005654 Clofentezine Substances 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000009849 Cucumis sativus Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-QLFBSQMISA-N Cyclohexane Natural products CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 1
- 239000005891 Cyromazine Substances 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 239000005892 Deltamethrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- WGOWCPGHOCIHBW-UHFFFAOYSA-N Dichlofenthion Chemical compound CCOP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl WGOWCPGHOCIHBW-UHFFFAOYSA-N 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- VBKKVDGJXVOLNE-UHFFFAOYSA-N Dioxation Chemical compound CCOP(=S)(OCC)SC1OCCOC1SP(=S)(OCC)OCC VBKKVDGJXVOLNE-UHFFFAOYSA-N 0.000 description 1
- 241000399934 Ditylenchus Species 0.000 description 1
- 239000005894 Emamectin Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000005895 Esfenvalerate Substances 0.000 description 1
- 239000005961 Ethoprophos Substances 0.000 description 1
- FGIWFCGDPUIBEZ-UHFFFAOYSA-N Etrimfos Chemical compound CCOC1=CC(OP(=S)(OC)OC)=NC(CC)=N1 FGIWFCGDPUIBEZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 description 1
- 239000005656 Fenazaquin Substances 0.000 description 1
- HMIBKHHNXANVHR-UHFFFAOYSA-N Fenothiocarb Chemical compound CN(C)C(=O)SCCCCOC1=CC=CC=C1 HMIBKHHNXANVHR-UHFFFAOYSA-N 0.000 description 1
- 239000005898 Fenoxycarb Substances 0.000 description 1
- 239000005657 Fenpyroximate Substances 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 239000005900 Flonicamid Substances 0.000 description 1
- 239000005780 Fluazinam Substances 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical class NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 1
- AIKKULXCBHRFOS-UHFFFAOYSA-N Formothion Chemical compound COP(=S)(OC)SCC(=O)N(C)C=O AIKKULXCBHRFOS-UHFFFAOYSA-N 0.000 description 1
- 239000005959 Fosthiazate Substances 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 241001442498 Globodera Species 0.000 description 1
- 241001442497 Globodera rostochiensis Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000498254 Heterodera glycines Species 0.000 description 1
- 241000379510 Heterodera schachtii Species 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 239000005661 Hexythiazox Substances 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- 239000005907 Indoxacarb Substances 0.000 description 1
- LFVLUOAHQIVABZ-UHFFFAOYSA-N Iodofenphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(I)C=C1Cl LFVLUOAHQIVABZ-UHFFFAOYSA-N 0.000 description 1
- XRHGWAGWAHHFLF-UHFFFAOYSA-N Isazofos Chemical compound CCOP(=S)(OCC)OC=1N=C(Cl)N(C(C)C)N=1 XRHGWAGWAHHFLF-UHFFFAOYSA-N 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 240000004322 Lens culinaris Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 241001220360 Longidorus Species 0.000 description 1
- 239000005912 Lufenuron Substances 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 239000005956 Metaldehyde Substances 0.000 description 1
- 241000223250 Metarhizium anisopliae Species 0.000 description 1
- NTAHCMPOMKHKEU-AATRIKPKSA-N Methacrifos Chemical compound COC(=O)C(\C)=C\OP(=S)(OC)OC NTAHCMPOMKHKEU-AATRIKPKSA-N 0.000 description 1
- 239000005951 Methiocarb Substances 0.000 description 1
- 239000005916 Methomyl Substances 0.000 description 1
- 239000005917 Methoxyfenozide Substances 0.000 description 1
- 239000005918 Milbemectin Substances 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 239000005950 Oxamyl Substances 0.000 description 1
- JAYZFNIOOYPIAH-UHFFFAOYSA-N Oxydeprofos Chemical compound CCS(=O)CC(C)SP(=O)(OC)OC JAYZFNIOOYPIAH-UHFFFAOYSA-N 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical compound ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000005921 Phosmet Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000005923 Pirimicarb Substances 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 241000500437 Plutella xylostella Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000193940 Pratylenchus penetrans Species 0.000 description 1
- DTAPQAJKAFRNJB-UHFFFAOYSA-N Promecarb Chemical compound CNC(=O)OC1=CC(C)=CC(C(C)C)=C1 DTAPQAJKAFRNJB-UHFFFAOYSA-N 0.000 description 1
- QTXHFDHVLBDJIO-UHFFFAOYSA-N Prothoate Chemical compound CCOP(=S)(OCC)SCC(=O)NC(C)C QTXHFDHVLBDJIO-UHFFFAOYSA-N 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 239000005925 Pymetrozine Substances 0.000 description 1
- 239000005663 Pyridaben Substances 0.000 description 1
- 239000005927 Pyriproxyfen Substances 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 241000201377 Radopholus Species 0.000 description 1
- 241000201375 Radopholus similis Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- OUNSASXJZHBGAI-UHFFFAOYSA-N Salithion Chemical compound C1=CC=C2OP(OC)(=S)OCC2=C1 OUNSASXJZHBGAI-UHFFFAOYSA-N 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 241000258242 Siphonaptera Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 239000005930 Spinosad Substances 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- 239000005938 Teflubenzuron Substances 0.000 description 1
- 239000005939 Tefluthrin Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000005940 Thiacloprid Substances 0.000 description 1
- 239000005941 Thiamethoxam Substances 0.000 description 1
- IRVDMKJLOCGUBJ-UHFFFAOYSA-N Thionazin Chemical compound CCOP(=S)(OCC)OC1=CN=CC=N1 IRVDMKJLOCGUBJ-UHFFFAOYSA-N 0.000 description 1
- OTLLEIBWKHEHGU-UHFFFAOYSA-N Thuringiensin Natural products C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 1
- 241000869417 Trematodes Species 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 241001220308 Trichodorus Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000005942 Triflumuron Substances 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241001267618 Tylenchulus Species 0.000 description 1
- 241001267621 Tylenchulus semipenetrans Species 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- CVQODEWAPZVVBU-UHFFFAOYSA-N XMC Chemical compound CNC(=O)OC1=CC(C)=CC(C)=C1 CVQODEWAPZVVBU-UHFFFAOYSA-N 0.000 description 1
- 241000201423 Xiphinema Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GBAWQJNHVWMTLU-RQJHMYQMSA-N [(1R,5S)-7-chloro-6-bicyclo[3.2.0]hepta-2,6-dienyl] dimethyl phosphate Chemical compound C1=CC[C@@H]2C(OP(=O)(OC)OC)=C(Cl)[C@@H]21 GBAWQJNHVWMTLU-RQJHMYQMSA-N 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- FZSVSABTBYGOQH-XFFZJAGNSA-N [(e)-(3,3-dimethyl-1-methylsulfanylbutan-2-ylidene)amino] n-methylcarbamate Chemical compound CNC(=O)O\N=C(C(C)(C)C)\CSC FZSVSABTBYGOQH-XFFZJAGNSA-N 0.000 description 1
- KAATUXNTWXVJKI-QPIRBTGLSA-N [(s)-cyano-(3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-QPIRBTGLSA-N 0.000 description 1
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 description 1
- QSGNQELHULIMSJ-POHAHGRESA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] dimethyl phosphate Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl QSGNQELHULIMSJ-POHAHGRESA-N 0.000 description 1
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 1
- CIAXFBVXQWOYPA-UHFFFAOYSA-N [C].[K] Chemical compound [C].[K] CIAXFBVXQWOYPA-UHFFFAOYSA-N 0.000 description 1
- INISTDXBRIBGOC-CGAIIQECSA-N [cyano-(3-phenoxyphenyl)methyl] (2s)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoate Chemical compound N([C@@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-CGAIIQECSA-N 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- YLFSVIMMRPNPFK-WEQBUNFVSA-N acrinathrin Chemical compound CC1(C)[C@@H](\C=C/C(=O)OC(C(F)(F)F)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YLFSVIMMRPNPFK-WEQBUNFVSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- GMAUQNJOSOMMHI-JXAWBTAJSA-N alanycarb Chemical compound CSC(\C)=N/OC(=O)N(C)SN(CCC(=O)OCC)CC1=CC=CC=C1 GMAUQNJOSOMMHI-JXAWBTAJSA-N 0.000 description 1
- QGLZXHRNAYXIBU-WEVVVXLNSA-N aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003302 alkenyloxy group Chemical group 0.000 description 1
- 125000005910 alkyl carbonate group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960002587 amitraz Drugs 0.000 description 1
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- VNKBTWQZTQIWDV-UHFFFAOYSA-N azamethiphos Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=O)(OC)OC)C2=N1 VNKBTWQZTQIWDV-UHFFFAOYSA-N 0.000 description 1
- ONHBDDJJTDTLIR-UHFFFAOYSA-N azocyclotin Chemical compound C1CCCCC1[Sn](N1N=CN=C1)(C1CCCCC1)C1CCCCC1 ONHBDDJJTDTLIR-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- XEGGRYVFLWGFHI-UHFFFAOYSA-N bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 description 1
- FYZBOYWSHKHDMT-UHFFFAOYSA-N benfuracarb Chemical compound CCOC(=O)CCN(C(C)C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 FYZBOYWSHKHDMT-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- VHLKTXFWDRXILV-UHFFFAOYSA-N bifenazate Chemical compound C1=C(NNC(=O)OC(C)C)C(OC)=CC=C1C1=CC=CC=C1 VHLKTXFWDRXILV-UHFFFAOYSA-N 0.000 description 1
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- ACBQROXDOHKANW-UHFFFAOYSA-N bis(4-nitrophenyl) carbonate Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC(=O)OC1=CC=C([N+]([O-])=O)C=C1 ACBQROXDOHKANW-UHFFFAOYSA-N 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- FOANIXZHAMJWOI-UHFFFAOYSA-N bromopropylate Chemical compound C=1C=C(Br)C=CC=1C(O)(C(=O)OC(C)C)C1=CC=C(Br)C=C1 FOANIXZHAMJWOI-UHFFFAOYSA-N 0.000 description 1
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 229940054025 carbamate anxiolytics Drugs 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229960005286 carbaryl Drugs 0.000 description 1
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- IRUJZVNXZWPBMU-UHFFFAOYSA-N cartap Chemical compound NC(=O)SCC(N(C)C)CSC(N)=O IRUJZVNXZWPBMU-UHFFFAOYSA-N 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 1
- UISUNVFOGSJSKD-UHFFFAOYSA-N chlorfluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1Cl)=CC(Cl)=C1OC1=NC=C(C(F)(F)F)C=C1Cl UISUNVFOGSJSKD-UHFFFAOYSA-N 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- QGTYWWGEWOBMAK-UHFFFAOYSA-N chlormephos Chemical compound CCOP(=S)(OCC)SCCl QGTYWWGEWOBMAK-UHFFFAOYSA-N 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical class OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 1
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- UXADOQPNKNTIHB-UHFFFAOYSA-N clofentezine Chemical compound ClC1=CC=CC=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 UXADOQPNKNTIHB-UHFFFAOYSA-N 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- SCKHCCSZFPSHGR-UHFFFAOYSA-N cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 description 1
- 125000000000 cycloalkoxy group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- LSFUGNKKPMBOMG-UHFFFAOYSA-N cycloprothrin Chemical compound ClC1(Cl)CC1(C=1C=CC=CC=1)C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 LSFUGNKKPMBOMG-UHFFFAOYSA-N 0.000 description 1
- 229960001591 cyfluthrin Drugs 0.000 description 1
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 1
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 description 1
- 229950000775 cyromazine Drugs 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 229960002483 decamethrin Drugs 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- WEBQKRLKWNIYKK-UHFFFAOYSA-N demeton-S-methyl Chemical compound CCSCCSP(=O)(OC)OC WEBQKRLKWNIYKK-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- HFPGRVHMFSJMOL-UHFFFAOYSA-N dibromomethane Chemical compound Br[CH]Br HFPGRVHMFSJMOL-UHFFFAOYSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical class OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 1
- 229950001327 dichlorvos Drugs 0.000 description 1
- VEENJGZXVHKXNB-VOTSOKGWSA-N dicrotophos Chemical compound COP(=O)(OC)O\C(C)=C\C(=O)N(C)C VEENJGZXVHKXNB-VOTSOKGWSA-N 0.000 description 1
- FAXIJTUDSBIMHY-UHFFFAOYSA-N diethoxy-(2-ethylsulfanylethoxy)-sulfanylidene-$l^{5}-phosphane;1-diethoxyphosphorylsulfanyl-2-ethylsulfanylethane Chemical compound CCOP(=O)(OCC)SCCSCC.CCOP(=S)(OCC)OCCSCC FAXIJTUDSBIMHY-UHFFFAOYSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- DLAPIMGBBDILHJ-UHFFFAOYSA-N dimethoxy-(3-methyl-4-methylsulfinylphenoxy)-sulfanylidene-$l^{5}-phosphane Chemical compound COP(=S)(OC)OC1=CC=C(S(C)=O)C(C)=C1 DLAPIMGBBDILHJ-UHFFFAOYSA-N 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- DOFZAZXDOSGAJZ-UHFFFAOYSA-N disulfoton Chemical compound CCOP(=S)(OCC)SCCSCC DOFZAZXDOSGAJZ-UHFFFAOYSA-N 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 244000079386 endoparasite Species 0.000 description 1
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- NYPJDWWKZLNGGM-RPWUZVMVSA-N esfenvalerate Chemical compound C=1C([C@@H](C#N)OC(=O)[C@@H](C(C)C)C=2C=CC(Cl)=CC=2)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-RPWUZVMVSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HEZNVIYQEUHLNI-UHFFFAOYSA-N ethiofencarb Chemical compound CCSCC1=CC=CC=C1OC(=O)NC HEZNVIYQEUHLNI-UHFFFAOYSA-N 0.000 description 1
- VJYFKVYYMZPMAB-UHFFFAOYSA-N ethoprophos Chemical compound CCCSP(=O)(OCC)SCCC VJYFKVYYMZPMAB-UHFFFAOYSA-N 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- YREQHYQNNWYQCJ-UHFFFAOYSA-N etofenprox Chemical compound C1=CC(OCC)=CC=C1C(C)(C)COCC1=CC=CC(OC=2C=CC=CC=2)=C1 YREQHYQNNWYQCJ-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 description 1
- DMYHGDXADUDKCQ-UHFFFAOYSA-N fenazaquin Chemical compound C1=CC(C(C)(C)C)=CC=C1CCOC1=NC=NC2=CC=CC=C12 DMYHGDXADUDKCQ-UHFFFAOYSA-N 0.000 description 1
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- XQUXKZZNEFRCAW-UHFFFAOYSA-N fenpropathrin Chemical compound CC1(C)C(C)(C)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 XQUXKZZNEFRCAW-UHFFFAOYSA-N 0.000 description 1
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 description 1
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 description 1
- YOWNVPAUWYHLQX-UHFFFAOYSA-N fluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C(OC=2C(=CC(=CN=2)C(F)(F)F)Cl)=C1 YOWNVPAUWYHLQX-UHFFFAOYSA-N 0.000 description 1
- 229950006719 fluazuron Drugs 0.000 description 1
- GBIHOLCMZGAKNG-CGAIIQECSA-N flucythrinate Chemical compound O=C([C@@H](C(C)C)C=1C=CC(OC(F)F)=CC=1)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 GBIHOLCMZGAKNG-CGAIIQECSA-N 0.000 description 1
- RYLHNOVXKPXDIP-UHFFFAOYSA-N flufenoxuron Chemical compound C=1C=C(NC(=O)NC(=O)C=2C(=CC=CC=2F)F)C(F)=CC=1OC1=CC=C(C(F)(F)F)C=C1Cl RYLHNOVXKPXDIP-UHFFFAOYSA-N 0.000 description 1
- FGIVSGPRGVABAB-UHFFFAOYSA-N fluoren-9-ylmethyl hydrogen carbonate Chemical class C1=CC=C2C(COC(=O)O)C3=CC=CC=C3C2=C1 FGIVSGPRGVABAB-UHFFFAOYSA-N 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- KVGLBTYUCJYMND-UHFFFAOYSA-N fonofos Chemical compound CCOP(=S)(CC)SC1=CC=CC=C1 KVGLBTYUCJYMND-UHFFFAOYSA-N 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- DUFVKSUJRWYZQP-UHFFFAOYSA-N fosthiazate Chemical compound CCC(C)SP(=O)(OCC)N1CCSC1=O DUFVKSUJRWYZQP-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- HAWJXYBZNNRMNO-UHFFFAOYSA-N furathiocarb Chemical compound CCCCOC(=O)N(C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 HAWJXYBZNNRMNO-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940052308 general anesthetics halogenated hydrocarbons Drugs 0.000 description 1
- WIFXJBMOTMKRMM-UHFFFAOYSA-N halfenprox Chemical compound C=1C=C(OC(F)(F)Br)C=CC=1C(C)(C)COCC(C=1)=CC=CC=1OC1=CC=CC=C1 WIFXJBMOTMKRMM-UHFFFAOYSA-N 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000005347 halocycloalkyl group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 229960000443 hydrochloric acid Drugs 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- QBSJMKIUCUGGNG-UHFFFAOYSA-N isoprocarb Chemical compound CNC(=O)OC1=CC=CC=C1C(C)C QBSJMKIUCUGGNG-UHFFFAOYSA-N 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- SDMSCIWHRZJSRN-UHFFFAOYSA-N isoxathion Chemical compound O1N=C(OP(=S)(OCC)OCC)C=C1C1=CC=CC=C1 SDMSCIWHRZJSRN-UHFFFAOYSA-N 0.000 description 1
- 229960002418 ivermectin Drugs 0.000 description 1
- 229930001540 kinoprene Natural products 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000521 lufenuron Drugs 0.000 description 1
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- KLGMSAOQDHLCOS-UHFFFAOYSA-N mecarbam Chemical compound CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC KLGMSAOQDHLCOS-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- GKKDCARASOJPNG-UHFFFAOYSA-N metaldehyde Chemical compound CC1OC(C)OC(C)OC(C)O1 GKKDCARASOJPNG-UHFFFAOYSA-N 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- NNKVPIKMPCQWCG-UHFFFAOYSA-N methamidophos Chemical compound COP(N)(=O)SC NNKVPIKMPCQWCG-UHFFFAOYSA-N 0.000 description 1
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 description 1
- YFBPRJGDJKVWAH-UHFFFAOYSA-N methiocarb Chemical compound CNC(=O)OC1=CC(C)=C(SC)C(C)=C1 YFBPRJGDJKVWAH-UHFFFAOYSA-N 0.000 description 1
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 description 1
- 229930002897 methoprene Natural products 0.000 description 1
- 229950003442 methoprene Drugs 0.000 description 1
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 description 1
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 1
- 229960001952 metrifonate Drugs 0.000 description 1
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003750 molluscacide Substances 0.000 description 1
- 230000002013 molluscicidal effect Effects 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 description 1
- 229960004816 moxidectin Drugs 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- ZUHZZVMEUAUWHY-UHFFFAOYSA-N n,n-dimethylpropan-1-amine Chemical compound CCCN(C)C ZUHZZVMEUAUWHY-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JUDKSMSHAHXBFK-UHFFFAOYSA-N n-ethylsulfamoyl chloride Chemical compound CCNS(Cl)(=O)=O JUDKSMSHAHXBFK-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229940079888 nitenpyram Drugs 0.000 description 1
- RBXVOQPAMPBADW-UHFFFAOYSA-N nitrous acid;phenol Chemical class ON=O.OC1=CC=CC=C1 RBXVOQPAMPBADW-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PZXOQEXFMJCDPG-UHFFFAOYSA-N omethoate Chemical compound CNC(=O)CSP(=O)(OC)OC PZXOQEXFMJCDPG-UHFFFAOYSA-N 0.000 description 1
- 150000002903 organophosphorus compounds Chemical class 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- KZAUOCCYDRDERY-UHFFFAOYSA-N oxamyl Chemical compound CNC(=O)ON=C(SC)C(=O)N(C)C KZAUOCCYDRDERY-UHFFFAOYSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical group COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 101150029756 petF gene Proteins 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 description 1
- BULVZWIRKLYCBC-UHFFFAOYSA-N phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- LMNZTLDVJIUSHT-UHFFFAOYSA-N phosmet Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)C(=O)C2=C1 LMNZTLDVJIUSHT-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 1
- 229950001664 phoxim Drugs 0.000 description 1
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 description 1
- 125000005547 pivalate group Chemical group 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000021039 pomes Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 description 1
- PWYIUEFFPNVCMW-UHFFFAOYSA-N propaphos Chemical compound CCCOP(=O)(OCCC)OC1=CC=C(SC)C=C1 PWYIUEFFPNVCMW-UHFFFAOYSA-N 0.000 description 1
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 description 1
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- QHMTXANCGGJZRX-WUXMJOGZSA-N pymetrozine Chemical compound C1C(C)=NNC(=O)N1\N=C\C1=CC=CN=C1 QHMTXANCGGJZRX-WUXMJOGZSA-N 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 229940015367 pyrethrum Drugs 0.000 description 1
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 description 1
- GWKKVWOEQGDUSY-UHFFFAOYSA-N pyridine;sodium Chemical compound [Na].C1=CC=NC=C1 GWKKVWOEQGDUSY-UHFFFAOYSA-N 0.000 description 1
- ITKAIUGKVKDENI-UHFFFAOYSA-N pyrimidifen Chemical compound CC1=C(C)C(CCOCC)=CC=C1OCCNC1=NC=NC(CC)=C1Cl ITKAIUGKVKDENI-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- PYODKQIVQIVELM-UHFFFAOYSA-M sodium;2,3-bis(2-methylpropyl)naphthalene-1-sulfonate Chemical compound [Na+].C1=CC=C2C(S([O-])(=O)=O)=C(CC(C)C)C(CC(C)C)=CC2=C1 PYODKQIVQIVELM-UHFFFAOYSA-M 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940014213 spinosad Drugs 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- XIUROWKZWPIAIB-UHFFFAOYSA-N sulfotep Chemical compound CCOP(=S)(OCC)OP(=S)(OCC)OCC XIUROWKZWPIAIB-UHFFFAOYSA-N 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- JXHJNEJVUNHLKO-UHFFFAOYSA-N sulprofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(SC)C=C1 JXHJNEJVUNHLKO-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- AWYOMXWDGWUJHS-UHFFFAOYSA-N tebupirimfos Chemical compound CCOP(=S)(OC(C)C)OC1=CN=C(C(C)(C)C)N=C1 AWYOMXWDGWUJHS-UHFFFAOYSA-N 0.000 description 1
- CJDWRQLODFKPEL-UHFFFAOYSA-N teflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(Cl)=C(F)C(Cl)=C1F CJDWRQLODFKPEL-UHFFFAOYSA-N 0.000 description 1
- WWJZWCUNLNYYAU-UHFFFAOYSA-N temephos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 description 1
- FGTJJHCZWOVVNH-UHFFFAOYSA-N tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)O[Si](C)(C)C(C)(C)C FGTJJHCZWOVVNH-UHFFFAOYSA-N 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 1
- DNVLJEWNNDHELH-UHFFFAOYSA-N thiocyclam Chemical compound CN(C)C1CSSSC1 DNVLJEWNNDHELH-UHFFFAOYSA-N 0.000 description 1
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 1
- OPASCBHCTNRLRM-UHFFFAOYSA-N thiometon Chemical compound CCSCCSP(=S)(OC)OC OPASCBHCTNRLRM-UHFFFAOYSA-N 0.000 description 1
- 229940074152 thuringiensin Drugs 0.000 description 1
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- AMFGTOFWMRQMEM-UHFFFAOYSA-N triazophos Chemical compound N1=C(OP(=S)(OCC)OCC)N=CN1C1=CC=CC=C1 AMFGTOFWMRQMEM-UHFFFAOYSA-N 0.000 description 1
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical class OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 125000006000 trichloroethyl group Chemical group 0.000 description 1
- 229960002415 trichloroethylene Drugs 0.000 description 1
- UGCNRZFAUBJVPT-UHFFFAOYSA-N tricyclohexyltin;hydrate Chemical compound O.C1CCCCC1[Sn](C1CCCCC1)C1CCCCC1 UGCNRZFAUBJVPT-UHFFFAOYSA-N 0.000 description 1
- XAIPTRIXGHTTNT-UHFFFAOYSA-N triflumuron Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl XAIPTRIXGHTTNT-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 244000045561 useful plants Species 0.000 description 1
- LESVOLZBIFDZGS-UHFFFAOYSA-N vamidothion Chemical compound CNC(=O)C(C)SCCSP(=O)(OC)OC LESVOLZBIFDZGS-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- WCJYTPVNMWIZCG-UHFFFAOYSA-N xylylcarb Chemical compound CNC(=O)OC1=CC=C(C)C(C)=C1 WCJYTPVNMWIZCG-UHFFFAOYSA-N 0.000 description 1
- 239000005943 zeta-Cypermethrin Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
Description
Avermectin B1 derivatives having an aminosulfonyloxy substituent in the 4"-position
The invention relates to (1) a compound of formula
R2 _
R3—N 7 - NO FU SE R o=— A ~~
Lo o” “o,, 23 0) 2 2 ZN oO “0. ES 0 25 0” “Ri (n 0.__0 xX on: lo)
OH wherein
Ry; is Ci-Cyalkyl, C3-Cgcycloalkyl; or C,-Cyoalkenyli;
R. is hydrogen, unsubstituted or mono- to penta-substituted C,-C;,alkyl or unsub- stituted or mono- to penta-substituted C,-Cyzalkenyl; unsubstituted or mono- to penta-sub- stituted C,-C,alkynyl; -C(O)R,4 or SO,Ry;
Rs is hydrogen, C,-Czalkyi, mono- to penta-substituted C,-C,zalkyl, unsubstituted or mono- to penta-substituted Cs-Cyocycloalkyl, unsubstituted or mono- to penta-substituted
C,-Cqalkenyl; or unsubstituted or mono- to penta-substituted C,-C,alkynyl; or
R. and Rj together are a three- to seven-membered alkylene bridge or a four- to seven-membered alkenylene bridge wherein one CH; group in the alkylene or alkenylene may have been replaced by O, S or NRs; or are a group =N"=N, and wherein the substituents of the alkyl, alkenyl, alkynyl, alkylene, alkenylene and cycloalkyl radicals defined under R; and Rj are selected from the group consisting of OH, halogen, halo-C,-C,alkyl, CN, NO,, C,-Cealkynyl; Cs-Cgcycloalkyl unsubstituted or substituted by from one to three methyl groups, norbornylenyl; Cs-Cgcycloalkenyl unsubstituted or substituted by from one to three methyl groups; Cs-Cghalocycloalkyl, C;-Cy.alkoxy, C4-Ce- alkoxy-C4-Cgalkyl, C,-Csalkoxy-C;-Cgalkoxy-C+-Csalkyl, Cs-Cgeycloalkoxy, Cq-Cizhaloalkoxy,
C1-Cpalkylthio, Ca-Cgeycloalkylthio, C,-Ciohaloalkylthio, C;-Cyaalkylsulfinyl, Cs-Cscycloalkyl-
‘WO-03/053988- PCT/EPO2/14671- sulfinyl, C;-Cyzhaloalkylsulfinyl, Cs-Cghalocycloalkylsulfinyl, C;-Cizalkyisulfonyl, C3-Cgeyclo- alkylsulfonyl, C4-Cyzhaloalkyisulfonyl, C4-Cghalocycloalkylsulfonyl, C,-Csalkenyl, C,-Cgalkynyl,
NH(C;-Cealkyl), N(C1-Csalkyl)z, -C(=0)Rs, -NHC(=0)Ry, -P(=0)(OC:-Cealkyl).; aryl, heterocyclyl, aryloxy, heterocyclyloxy; and aryl, heterocyclyl, aryloxy and heterocyclyloxy that, depending upon the possibilities of substitution at the ring, are mono- to penta- substituted by substituents selected from the group consisting of OH, halogen, CN, NO,
C4-Coalkyl, Ca-Cgcycloalkyl, Ci-Cyzhaloalkyl, C-Cr2alkoxy, C;-Cyzhaloalkoxy, C4-Cyqalkylthio,
C4-Cyzhaloalkylthio, Ci-Cealkoxy-C4-Cealkyl, dimethylamino-Cs-Cealkoxy, Co-Cgalkenyl, Co-Cs- alkynyl, phenoxy, phenyl-C;-Csalkyl; phenoxy unsubstituted or substituted by from one to three substituents selected independently of one another from halogen, methoxy, trifluoro- methyl and trifluoromethoxy; phenyl-C,-Cealkoxy unsubstituted or substituted in the aromatic ring by from one to three substituents selected independently of one another from halogen, methoxy, trifluoromethyl and trifluoromethoxy; phenyl-C.-Cealkenyl, phenyl-C,-Cgalkynyl, methylenedioxy, -C(=O)R4, -O-C(=0)R7, -NH-C(=O)Ry7, NHz, NH(C1-Ci2alkyl),
N(C+-C1zalkyl),, C4-Cealkylsulfinyl, Cs-Cgscycloalkylsulfinyl, C4-Cghaloalkylsuifinyl, Cs-Cghalo- cycloalkylsulfinyl, C,-Cealkylsulfonyl, Ca-Cgcycloalkylsulfonyl, C,-Cghaloalkylsulfonyl and
C3-Cghalocycioalkylsulfonyl;
Rs is H, OH, C4-Cgalkyl, C1-Cgalkyl mono- to hepta-substituted by halogen, nitro,
C4-Cgalkoxy, OH, SH, NH,, NH(C4-Cizalkyl) or N(C4-Caalkyl)z; C4-Cgalkoxy, halo-C4-Cg- alkoxy, Cs-Cscycloalkyl, Ca-Cscycloalkoxy, Co-Csalkenyl, Co-Cgalkenyloxy, C,-Cgalkynyl,
C.,-Cgalkynyloxy, NHz, NH(C4-Cizalkyl), N(C4-Cizalkyl)z, aryl, aryloxy, benzyl, benzyloxy, heterocyclyl, heterocyclyloxy, heterocyclyimethyl or heterocyclylmethoxy; wherein the radi- cals aryl, aryloxy, benzyl, benzyloxy, heterocyclyl, heterocyclyloxy, heterocyclylmethyl and heterocyclylmethoxy are unsubstituted or, depending upon the possibilities of substitution at the ring, are substituted by from one to three substituents selected independently of one another from halogen, C4-Cizalkyl, C4-Cyzhaloalkyl, C4-Ciealkoxy, Cq-Cizhaloalkoxy, C,-Cealk- oxy-Ci-Cealkoxy, C;-Crzalkylthio, C4-Cyzhaloalkylthio, C,-Cgalkenyloxy, C,-Cgalkynyloxy, nitro and cyano; :
Rs is Ci-Cgalkyl, Cs-Cycycloalkyl, Co-Cgalkenyl, C»-Cgalkynyl, benzyl or -C(=0)-Re;
Rs is H, OH, SH, NH,, NH(C+-Cyzalkyl), N(C4-Cizalkyl)z, C1-Ciaalkyl, C4-Cizhaloalkyi,
C-Cyzalkoxy, Ci-Cizhaloalkoxy, Cs-Cealkoxy-Ci-Cealkoxy, C;-Cyealkyithio, C,-Cgalkenyloxy,
C,-Cgalkynyloxy; phenyl, phenoxy, benzyloxy, NH-phenyl, N(C;-Csalkyl)-phenyl, NH-C;-Ce- alkyl-C(=0)-Ra, N(C;-Calkyl)-Cy-Cealkyl-C(=0)-Rs; or phenyl, phenoxy, benzyloxy,
NH-phenyl or N(C;-Csalkyl)}—phenyl each of which is substituted in the aromatic ring by from one to three substituents selected independently of one another from halogen, C;-Cealkoxy,
C,-Cshaloalkyl and C,-Cghaloalkoxy;
R, is H, C4-Cyzalkyl, C4-Cizhaloalkyl, C,-Cgalkenyl, Co-Cgalkynyl, phenyl, benzyl,
NH,, NH(C;-C.alkyl), N(C4-Cioalkyl)., NH-phenyl or N(C;-C1oalkyl)-phenyl; and oo Co
Rs is H, OH, C4-Calkyl, C4-Cqzalkoxy, C,-Csalkoxy-C4-Cealkoxy, C,-Csalkenyloxy, - phenyl, phenoxy, benzyloxy, NH, NH(C,-C1zalkyl), N(C4-Cizalkyl),, NH-phenyl or N(C4-Ci2- alkyl)-phenyl; and, where applicable, to E/Z isomers, mixtures of E/Z isomers and/or tautomers, in each case in free form or in salt form; to a process for the preparation of and to the use of those compounds and their iso- mers and tautomers; to starting materials for the preparation of the compounds of formula (1); to pesticidal compositions in which the active ingredient has been selected from the compounds of formula (1) and their tautomers; and to a method of controlling pests using those compositions.
Hereinbefore and hereinafter, the bond marked by the symbol in formulae (1), (I) and (IV) indicates that at the 4"-position the S- as well as the R-isomer is meant.
Certain macrolide compounds are proposed for pest control in the literature. The bio- logical properties of those known compounds are not entirely satisfactory, however, for which reason there is a need to provide further compounds having pesticidal properties, especially for the control of insects and members of the order Acarina. That problem is solved according to the invention by the provision of the present compounds of formula (1).
The compounds claimed according to the invention are derivatives of avermectin.
Avermectins are known to the person skilled in the art. They are a group of structurally closely related pesticidally active compounds which are obtained by fermentation of a strain of the microorganism Streptomyces avermitilis. Derivatives of avermectins can be obtained via conventional chemical syntheses.
The avermectins obtainable from Streptomyces avermitilis are designated Ala, Alb,
A2a, A2b, Bla, Bib, B2a and B2b. Compounds with the designation “A” have a methoxy radical in the 5-position; those compounds designated “B” have an OH group. The “a” series comprises compounds wherein the substituent Ry (in position 25) is a sec-butyl radical; in the “v7 series there is an isopropyl radical in the 25-position. The number 1 in the name ofa
—WO-63/653988- PCT/EPO2/14671 compound indicates that atoms 22 and 23 are bonded by a double bond; the number 2 indicates that they are bonded by a single bond and carbon atom 23 carries an OH group.
The above designations are retained in the description of the present invention in order in the case of the non-natural avermectin derivatives according to the invention to indicate the specific structural type corresponding to natural avermectin. There are claimed according to the invention derivatives of compounds of the B1 series, more especially mixtures of derivatives of avermectin Bia and B1b having, at the 4"-position, either the S- or the
R-configuration.
Some of the compounds of formula (1) may be in the form of tautomers. Accordingly, any reference to the compounds of formula (I) hereinbefore and hereinafter is to be under- stood, where applicable, as including also corresponding tautomers, even if the latter are not specifically mentioned in every case.
The compounds of formula (1) and, where applicable, their tautomers can form salts, for example acid addition salts. These acid addition salts are formed, for example, with strong inorganic acids, such as mineral acids, for example sulfuric acid, a phosphoric acid or a hydrohalic acid, with strong organic carboxylic acids, such as unsubstituted or substituted, for example halo-substituted, C,-C,alkanecarboxylic acids, for example acetic acid, unsaturated or saturated dicarboxylic acids, for example oxalic acid, malonic acid, maleic acid, fumaric acid or phthalic acid, hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or benzoic acid, or with organic sulfonic acids, such as unsubstituted or substituted, for example halo-substituted, C,-Cjalkane- or aryl- sulfonic acids, for example methane- or p-toluene-sulfonic acid. Compounds of formula (1) that have at least one acidic group can furthermore form salts with bases. Suitable salts with bases are, for example, metal salts, such as alkali metal salts or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or with an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower alkyl- amine, for example ethylamine, diethylamine, triethylamine or dimethylpropylamine, or a mono-, di- or trihydroxy-lower alkylamine, for example mono-, di- or tri-ethanolamine. Corre- sponding internal salts may also be formed where appropriate. The free form is preferred.
Among the salts of the compounds of formula (1), the agrochemically advantageous salts are preferred. Hereinbefore and hereinafter, any reference to the free compounds of formula 1) or their salts is to be understood as including, where appropriate, also the corresponding salts or the free compounds of formula (1), respectively. The same applies to tautomers of compounds of formula (1) and salts thereof.
Unless defined otherwise, the general terms used hereinbefore and hereinafter have the meanings given below.
Unless defined otherwise, carbon-containing groups and compounds each contain from 1 up to and including 6, preferably from 1 up to and including 4, especially 1 or 2, - carbon atoms.
Halogen - as a group per se and as a structural element of other groups and com- pounds, such as haloalkyl, haloalkoxy and haloalkylthio - is fluorine, chlorine, bromine or iodine, especially fluorine, chlorine or bromine, more especially fluorine or chlorine.
Alkyl - as a group per se and as a structural element of other groups and compounds, such as haloalkyl, alkoxy and alkylthio - is, in each case giving consideration to the number of carbon atoms contained in the group or compound in question, either straight-chained, i.e. methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl or octyl, or branched, e.g. isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl or isohexyl.
Cycloalkyl - as a group per se and as a structural element of other groups and com- pounds, such as halocycloalkyl, cycloalkoxy and cycloalkyithio - is, in each case giving due consideration to the number of carbon atoms contained in the group or compound in ques- tion, cyclopropyl, cyciobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.
Alkenyl - as a group per se and as a structural element of other groups and com- pounds - is, giving due consideration to the number of carbon atoms and conjugated or isolated double bonds contained in the group in question, either straight-chained, e.g. vinyl, allyl, 2-butenyl, 3-pentenyi, 1-hexenyl, 1-heptenyl, 1,3-hexadienyl or 1,3-octadienyl, or branched, e.g. isopropenyl, isobutenyl, isoprenyl, tert-pentenyl, isohexenyl, isoheptenyl or isooctenyl. Alkenyl groups having from 3 to 12, especially from 3 to 6, more especially 3 or 4, carbon atoms are preferred.
Alkyny! - as a group per se and as a structural element of other groups and com- pounds - is, in each case giving due consideration to the number of carbon atoms and con- jugated or isolated double bonds contained in the group or compound in question, either straight-chained, e.g. ethynyl, propargyl, 2-butynyl, 3-pentynyl, 1-hexynyl, 1-heptynyl, 3- hexen-1-ynyl or 1,5-heptadien-3-ynyl, or branched, e.g. 3-methylbut-1-ynyl, 4-ethylpent-1- ynyl, 4-methylhex-2-ynyl or 2-methylhept-3-ynyl. Alkynyl groups having from 3 to 12, especially from 3 to 6, more especially 3 or 4, carbon atoms are preferred.
WO-03/053988— ~PCTEPO/H6TL
Alkylene and alkenylene are straight-chained or branched bridge members, especially ~CHy-CHy-CHa-, -CHy-CH,-CHa-CHp-, -CHz-CH,-CH2-CH,-CHe-, -CH3(CH3)CH,-CHo-, -CH,C(CHa3)2-CHz-, -CH,-CH=CH-CH_- or -CH,-CH=CH-CH>-CH,-.
Halo-substituted carbon-containing groups and compounds, such as alkyl, alkenyl, alkynyl, cycloalkyl, alkoxy or alkylthio substituted by halogen, may be partially halogenated or perhalogenated, it being possible in the case of polyhalogenation for the halogen sub- stituents to be the same or different. Examples of haloalkyl - as a group per se and as a structural element of other groups and compounds, such as haloalkoxy and haloalkylthio - are methyl substituted from one to three times by fluorine, chlorine and/or bromine, such as
CHF, or CF; ethyl substituted from one to five times by fluorine, chlorine and/or bromine, such as CH,CFs3, CF.CFa, CF,CCls, CF,CHCl,, CF.CHF,, CF.CFCl,, CF.CHBr2, CF.CHCIF,
CF,CHBIF or CCIFCHCIF; propyl or isopropyl substituted from one to seven times by fluorine, chlorine and/or bromine, such as CH,CHBrCH:Br, CF.CHFCF3;, CH.CF,CF; or
CH(CF,)z; butyl or an isomer thereof substituted from one to nine times by fluorine, chorine and/or bromine, such as CF(CF;)CHFCF; or CHy(CF>) CFs; pentyl or an isomer thereof substituted from one to eleven times by fluorine, chlorine and/or bromine, such as
CF(CF3)(CHF),CF; or CH,(CF2);CFs; and hexyl or an isomer thereof substituted from one to thirteen times by fluorine, chlorine and/or bromine, such as (CH,),CHBrCH.Br,
CF(CHF)4CF3, CHy(CF,)4CF3 or C(CF3)2(CHF),CFa. :
Aryl is especially phenyl, naphthyl, anthracenyl or perylenyl, preferably phenyl.
Heterocyclyl is especially pyridyl, pyrimidyl, s-triazinyl, 1,2,4-triazinyl, thienyl, furyl, tetrahydrofuranyl, pyranyl, tetrahydropyranyl, pyrrolyl, pyrazolyl, imidazolyl, thiazolyl, triazolyl, tetrazolyl, oxazolyl, thiadiazolyl, oxadiazolyl, benzothienyl, quinolinyl, quinoxalinyl, benzo- furany!, benzimidazolyl, benzopyrrolyl, benzothiazolyl, indolyl, coumarinyl or indazolyl, which are preferably bonded via a carbon atom; preference is given to thienyl, thiazolyl, benzo- furanyl, benzothiazolyl, furyl, tetrahydropyranyl and indolyl; especially pyridyl or thiazolyl.
Within the scope of the present invention, preference is given to (2) compounds according to group (1) of formula (1) wherein R, is isopropyl or sec- butyl, preferably wherein a mixture of the isopropyl and the sec-butyl derivative is present; (3) compounds according to group (2) of formula (I) wherein R; is H, C4-Cgalkyl, Cy-Cg- alkyl mono- to penta-substituted by halogen, OH or CN; C5-Cjyzalkenyl, Cs-Cyoalkynyl or
C(O)Ra;
(4) compounds according to one of groups (1) to (3) of formula (I) wherein R; is
C,-C.alkyl, especially methyl; (5) compounds according to group (2) of formula (I) wherein Ris ethyl; (6) compounds according to group (2) of formula (1) wherein Rz is n-propyl; (7) compounds according to one of groups (1) to (6) of formula (I) wherein Rg is H,
C,-Cgalkyl, C,-Cgalkyl substituted by halogen, OH or CN; C5-Cioalkenyl or Cs-Cyalkynyl; (8) compounds according to one of groups (1) to (6) of formula (I) wherein Rs is H; (9) compounds according to one of groups (1) to (6) of formula (I) wherein Rj; is methyl; (10) compounds according to one of groups (1) to (6) of formula (I) wherein Rj is ethyl; (11) compounds according to one of groups (1) to (6) of formula (I) wherein Rs is n-propyl; (12) compounds according to one of groups (1) to (6) of formula (I) wherein Rj is iso- propyl; (13) compounds according to one of groups (3) and (7) to (12) of formula (I) wherein
R, is H, OH, C;-Caalkyl, C;-C,alkoxy, halo-C,-Caalkyl, halo-C;-Csalkoxy, Cs-Cgcycloalkoxy,
C.-Cgalkenyloxy, C»-Cgalkynyloxy, NH,, NH(C1-Cizalkyl), N(C1-Cizalkyl),, aryl, aryloxy, benzyl or benzyloxy; wherein the radicals aryl, aryloxy, benzyl and benzyloxy are unsubstituted or substituted by from one to three substituents selected independently of one another from halogen, C;-Calkyl, C;-Cshaloalkyl, C4-Cjalkoxy, C;-Cshaloalkoxy, C4-Cyzhaloalkylthio, nitro and cyano; (14) compounds according to one of groups (1) and (2) of formula (I) wherein Rp and
Rs together are -CH»>-CH»>-CH»- or -CH,-CH,-CH,-CH,-; (15) compounds according to one of groups (1) and (2) of formula (I) wherein R, and
Rs together are -CHp-CHo-O-CHp-CHa- or -CHz-CH,-N(CHg)-CHa-CHo-; (16) compounds according to one of groups (1) and (7) to (12) of formula (1) wherein
R, is substituted C,-Caalkyl, especially -CH,-, and the substituents are selected from the group consisting of OH, CN, halogen, Cs-Cgcycloalkyl; Ca-Cgeycloalkenyl unsubstituted or substituted by from one to three methyl groups; C4-Cizalkoxy, Co-Cgalkynyl, -C(=0)Ry, -NHC(=0)Rs, -P(=0)(0OC4-Cealkyl),; and phenyl, naphthyl, anthracenyl, phenanthrenyl, fluo-
—WO-03/053988— —PCT/EPO2AH46T1 renyl, perylenyl and heterocyclyl which are unsubstituted or, depending upon the possibilities of substitution at the ring, mono- to penta-substituted; . especially wherein the substituents of R; are selected from the group consisting of halogen, CN, Ca-Cgcycloalkyl, C-Cgalkynyl, -C(=0)R., -NHC(=0)Rg, -P(=0)(OC;-Cgalkyl)z; ] and phenyl, naphthyl, anthracenyl, pyridyl, thiazolyl, imidazolyl, furyl, quinolinyl and pyrazolyl which are unsubstituted or, depending upon the possibilities of substitution at the ring, mono- to tri-substituted,; (17) compounds according to one of groups (1) to (8) and (16) of formula (I) wherein
Rs is benzyl that carries on the aromatic moiety from one to three substituents that are selected from the group consisting of OH, halogen, CN, NO, C,-C:alkyl, dimethylamino-
C;-Caalkoxy, Cs-Cecycloalkyl, Ci-Czhaloalkyl, C4-Caalkoxy, C;-Cshaloalkoxy, phenoxy, phenyl-C;-Cealkyl, phenyl-C,-C,alkenyl; phenoxy unsubstituted or substituted by chlorine or methoxy; benzyloxy unsubstituted or substituted by chlorine, methoxy or trifluoromethyl; methylenedioxy, -C(=O)Rs, -O-C(=0)Rs and NHC(=0)Re;
Rs is H, OH, NH,, NH(C:-Czalkyl), N(C4-Czalkyl)., -0-C,-Calkyl-C(=0)-Ry,
NHC;-C.alkyl-C(=0)-R;, C:-Cealkyl, C;-Coalkoxy, C,-C.alkoxy-C,-Cqalkoxy, C,-Cialkenyloxy,
C,-Caalkynyloxy; phenyl, phenoxy, benzyloxy, NH-phenyl, NH-C,-Cgalkyl-C(=0)-Ry; or phenyl, phenoxy, benzyloxy or NH-phenyl substituted by halogen, nitro, methoxy, trifluoro- methyl or trifluoromethoxy;
Rs is H, Ci-Caalkyl, phenyl or benzyl; and
R, is H, OH, NH, NH(C,-Cyqalkyl), N(C1-C2alkyl),, C4-Cqoalkyl, C,-Cialkoxy,
C,-Csalkoxy-C1-Cgalkoxy, Co-Cgalkenyloxy, phenyl, phenoxy, benzyloxy or NH-phenyl, (18) compounds according to one of groups (1) to (6) of formula (I) wherein Rs is
C4-Caalkyl-C(=0)Rs, especially -CH,-C(=0)Rs; and
Rs is H, OH, NH,, NH(C;-Coalkyl), N(Cy-Coalkyl),, Ci-Caalkyl, C;4-Cqzalkoxy, oo C,-C,alkenyloxy, phenyl; phenoxy, benzyloxy, NH-phenyl, NH-C;-Cralkyl-C(=0)-0-C4-Cz- CL alkyl-phenyl, -P(=0)(OC;-Cgalkyl)z; or phenyl, phenoxy, benzyloxy or NH-phenyl substituted ’ by chlorine, fluorine, methoxy, trifluoromethyl or trifluoromethoxy; more especially wherein Rs is C-Cqzalkoxy; (19) compounds according to one of groups (1) to (6) of formula (I) wherein Ry is unsubstituted benzyl;
(20) compounds according to one of groups (1) to (19) of formula (I) that have the R configuration at the 4"-position; (21) compounds according to one of groups (1) to (19) of formula (1) that have the S configuration at the 4"-position. -- Special preference-is-given-withinthe-scope-of the invention to compounds P.1 to P.17 ~~ and to the compounds of formula (J) listed in Tables 1 to 3 and, where applicable, their E/Z isomers and mixtures of E/Z isomers.
The invention further relates to a process for the preparation of the compounds of formula (I) as defined above under (1) and, where applicable, tautomers thereof, which com- prises (A) reacting a compound of formula oo”
HO, 4 oo” 0” ™o,, 23 0” 0. AL 0 »s 0” “Ri (in, . °%° oH: i
Q wherein the bond marked by “indicates the S- as well as the R-isomer at the 4"-position; wherein R; is as defined above under (1) for formula (I) and Q is a protecting group, and which is known or can be prepared by methods known per se, with a compound of formula 2
Hal Rs an 2
HS wherein R; and Rj are as defined above for formula (I) and Hal is a halogen atom, preferably bromine or iodine, and which is known or can be prepared by methods known per
“WO-03/053988— —PCT/EPO2/H6TL se, to form a compound of formula
R2 : / oo” f R1
Ra—N o J 0 o Be (v), e, _ 7 re, oe o=, [o} ok \ \ , f 2 0—Q 0) wherein Q, R;, R, and Rj are as defined for formula (11); and (B) removing the protecting group Q of the compound of formula (1V) so obtained; or (C) reacting a compound of formula (1) wherein R; and R; are as defined for formula (1) and R; is H, with a compound of the formula Hal-R, wherein R; is as defined for formula (1) and Hal is halogen, especially bromine or iodine; or (D) reacting a compound of formula (IV) wherein Q, R; and Rj; are as defined for formula (IV) and R; is H, with a compound of the formula Hal-R, wherein R; is as defined for formula (1) and Hal is halogen, especially bromine or iodine; and removing the protecting group Q from the compound of formula (IV) so obtained analogously to process step (B); or (E) for the preparation of a compound of formula (I) wherein R; is as defined for formula (}) and R, and R; are identical and, with the exception of hydrogen, are as defined for formula (1), reacting a compound of formula (I) wherein R; is as defined for formula (1) and R, and R; are H, with two moles of a compound of the formula Hal-R; wherein R; is as defined for formula (1) and Hal is halogen, especially bromine or iodine; or reacting a compound of formula (IV) wherein R, is as defined for formula (IV) and R; and Rs are H, with two moles of a compound of the formula Hal-R. wherein R; is as defined for formula (I) and
Hal is halogen, especially bromine or iodine; and then removing the protecting group Q analogously to process step (B); or I (F) for the preparation of a compound of formula (I) wherein R; is as defined for formula (I) and R; and Rj together are a three- to seven-membered alkylene bridge or a . four- to seven-membered alkenylene bridge wherein one CH, group in the alkylene or alkenylene may have been replaced by O, S or NRs, reacting a compound of formula (1) wherein R; is as defined for formula (I) and R, and Rj are H, with one mole of a compound of the formula Hal-A-Hal wherein the bridge member A has the above-mentioned definition : of R, and Rj; together and Hal is halogen, especially bromine or iodine; or, analogously to process step (E), reacting a compound of formula (IV) wherein R, and Q are as defined for : formula (IV) and R; and Rj; are H, with one mole of a compound of the formula Hal-A-Hal as defined above, and then removing the protecting group Q analogously to process step (B); or Ss (G) for the preparation of a compound of formula (I) wherein R; is -C(O)R,; and Ry, Rs and R, are as defined for formula (I), either reacting a compound of formula (I) wherein R; and Rj are as defined for formula (I) and R; is H, with a compound of the formula
Hal-C(O)R; wherein R; is as defined above for formula (1) and Hal is halogen; or reacting a compound of formula (IV) wherein R,, R3, R; and Q are as defined for formula (1) and R; is
H, with a compound of the formula Hal-C(O)R, wherein R, is as defined above for formula (I) and Hal is halogen; and then removing the protecting group Q.
The remarks made above regarding tautomers of compounds of formula (I) apply analogously to the starting materials mentioned hereinbefore and hereinafter with regard to their tautomers.
The reactions described hereinbefore and hereinafter are carried out in a manner - known per se, for example in the absence or, customarily, in the presence of a suitable solvent or diluent or of a mixture thereof, the reactions being carried out, as required, with cooling, at room temperature or with heating, for example in a temperature range of approximately from -80°C to the boiling temperature of the reaction medium, preferably from approximately 0°C to approximately +150°C, and, if necessary, in a closed vessel, under pressure, under an inert gas atmosphere and/or under anhydrous conditions. Especially advantageous reaction conditions can be found in the Examples.
The reaction time is not critical; a reaction time of from approximately 0.1 to approximately 72 hours, especially from approximately 0.5 to approximately 24 hours, is preferred. )
The product is isolated by customary methods, for example by means of filtration, crystallisation, distillation or chromatography, or any suitable combination of such methods.
The starting materials mentioned hereinbefore and hereinafter that are used for the preparation of the compounds of formula (I) and, where applicable, their tautomers are known or can be prepared by methods known per se, e.g. as indicated below.
The starting materials of formula oo”
HO, 4 oo” Tv 0” "0, ) ’ 2 0 0., IN 0 25 oo © Rl (la),
O° on:
S : 0
Q and the compounds of formula 0”
HO
. oo” 0” 0, ’ 23 4, 22 ~ ot 0 ‘0, EN Oo 25 © Rab),
ENG on: 0} 0
Q wherein Ry and Q are as defined above are known to the person skilled in the art (abamectin Bla or 4"-epi-abamectin B1a each provided with a protecting group in the 5-position) or can be prepared by methods known per se. BN oo
Process variant (A): }
Examples of solvents and diluents include: aromatic, aliphatic and alicyclic hydro- ) carbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichlorobenzene, bromobenzene, petroleum ether, hexane, cyclo- hexane, dichloromethane, trichloromethane, tetrachloromethane, dichloroethane, trichloro- ethene or tetrachloroethene; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether,
dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyi ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxydiethyl ether, tetrahydrofuran or dioxane; esters of carboxylic acids, such as ethyl acetate; amides, such as dimethyl- formamide, dimethylacetamide or 1-methyl-2-pyrrolidinones; nitriles, such as acetonitrile; sulfoxides, such as dimethyl sulfoxide; or mixtures of the mentioned solvents. Preference is given to amides, such as dimethylformamide and dimethylacetamide, especially dimethyl- acetamide.
Protecting groups Q in the compounds of formulae (Il) and (IV) include: alky! ether radicals, such as methoxymethyl, methylthiomethyl, tert-butylthiomethyl, benzyloxymethyl, p- methoxybenzyl, 2-methoxyethoxymethyl, 2,2,2-trichloroethoxymethyl, 2-(trimethyl- : silyl)ethoxymethyl, tetrahydropyranyl, tetrahydrofuranyl, 1-ethoxyethyl, 1-(2-chloro- ethoxy)ethyl, 1-methyl-1-methoxyethyl, 1-methyl-1-benzyloxyethyl, trichloroethyl, 2-tri- methyisilylethyl, tert-butyl, allyl, p-methoxyphenyl, 2,4-dinitrophenyl, benzyl}, p-methoxy- benzyl, o-nitrobenzyl, p-nitrobenzyl, triphenylmethyl; trialkylsilyl radicals, such as trimethyl- silyl, triethylsilyl, dimethyl-tert-butylsilyl, dimethyl-isopropyisilyl, dimethyl-1,1,2-trimethyl- propylsilyl, diethyl-isopropyisilyl, dimethyl-tert-hexylsilyl, but also phenyl-tert-alkylsilyl groups, such as diphenyl-tert-butylsilyl; esters, such as formates, acetates, chloroacetates, di- chloroacetates, trichloroacetates, trifluoroacetates, methoxyacetates, phenoxyacetates, pivaloates, benzoates; alkyl carbonates, such as methyl-, 9-fluorenylmethyl-, ethyl-, 2,2,2-tri- chloroethytl-, 2-(trimethylsilyl)ethyl-, vinyl-, allyl-, benzyl-, p-methoxybenzyl-, o-nitrobenzyl-, p-nitrobenzyl-, but also p-nitrophenyl-carbonate.
Preference is given to trialkylsilyl radicals, such as trimethylsilyl, triethylsilyl, dimethyl- tert-butylsilyl, diphenyl-tert-butylsilyl, esters, such as methoxyacetates and phenoxyacetates, and carbonates, such as 9-fluorenylmethylcarbonates and allylcarbonates. Dimethyl-tert- butylsilyl ether is especially preferred.
The reactions are advantageously carried out in a temperature range of from approximately -70°C to 50°C, preferably at from -10°C to 25°C.
Especially preferred conditions for the reaction are described in Example P.1.
Process variant (B):
Examples of solvents and diluents are the same as those mentioned under Process variant A. In addition, alcohols, such as methanol, ethanol or 2-propanol, and water are suitable.
The reactions are advantageously carried out in a temperature range of approx- imately from -70°C to 100°C, preferably at from -10°C to 25°C.
There are suitable for the removal of the protecting group Lewis acids, such as hydro- chloric acid, methanesulfonic acid, BF;*OEt,, HF in pyridine, Zn(BF,).*H.0, p-toluenesulfonic acid, AlCl, HgCl,; ammonium fluoride, such as tetrabutylammonium fluoride; bases, such as ammonia, trialkylamine or heterocyclic bases; hydrogenolysis with a catalyst, such as palladium-on-carbon; reducing agents, such as sodium borohydride or tributyltin hydride with a catalyst, such as Pd(PPhs),, or also zinc with acetic acid.
Preference is given to acids, such as methanesulfonic acid or HF in pyridine; sodium borohydride with Pd(0); bases, such as ammonia, triethylamine or pyridine; especially acids, such as HF in pyridine or methanesuifonic acid.
Especially preferred conditions for the reaction are described in Example P.1.
Process variant (C): :
Examples of solvents and diluents are the same as those mentioned under Process variant (A). In addition, alcohols, such as methanol, ethanol or 2-propanol, are suitable.
Preference is given to amides, such as dimethylformamide, and nitriles, such as acetonitrile; especially acetonitrile.
The reactions are advantageously carried out in a temperature range of approximately from -10°C to 120°C, preferably at from 20°C to 100°C.
Suitable bases are especially carbonates, such as sodium carbonate, sodium hydro- gen carbonate, potassium carbonate, trialkylamines, such as triethylamine, and heterocyclic bases, such as pyridine.
Especially preferred conditions for the reaction are described in Example P.4.
Process variants (D) to (F) are carried out substantially analogously to Process variant
Process variant (G): )
Examples of solvents and diluents are the same as those mentioned under Process } variant (B).
Ethyl acetate and water are preferred.
The reactions are advantageously carried out in a temperature range of approximately from -10°C to 120°C, preferably at from 20°C to 80°C.
Suitable bases are especially carbonates, such as sodium carbonate, sodium hydro- gen carbonate, potassium carbonate, trialkylamines, such as triethylamine, and heterocyclic } . bases, such as pyridine. _
Especially preferred conditions for the reaction are described in Example P.11.
The compounds of formula (I) may be in the form of one of the possible isomers or in the form of a mixture thereof, in the form of pure isomers or in the form of an isomeric mix- ture, i.e. in the form of a racemic mixture; the invention relates both to the pure isomers and to the racemic mixtures and is to be interpreted accordingly hereinbefore and hereinafter, even if stereochemical details are not mentioned specifically in every case.
The racemates can be resolved into the optical antipodes by known methods, for example by recrystallisation from an optically active solvent, by chromatography on chiral adsorbents, for example high pressure liquid chromatography (HPLC) on acetylcellulose, with the aid of suitable microorganisms, by cleavage with specific, immobilised enzymes, or via the formation of inclusion compounds, for example using chiral crown ethers, only one isomer being complexed.
Apart from by separation of corresponding mixtures of isomers, pure optical isomers can be obtained according to the invention also by generally known methods of enantio- selective synthesis, for example by carrying out the process according to the invention using starting materials having correspondingly suitable stereochemistry.
In each case it is advantageous to isolate or synthesise the biologically more active isomer, where the individual components have different biological activity.
The compounds of formula (I) may also be obtained in the form of their hydrates and/or may include other solvents, for example solvents which may have been used for the crystallisation of compounds in solid form.
The invention relates to all those embodiments of the process according to which a compound obtainable as starting material or intermediate at any stage of the process is used as starting material and some or all of the remaining steps are carried out or a starting material is used in the form of a derivative or salt and/or its racemates or antipodes or, especially, is formed under the reaction conditions.
WO-63/6053988- PCTEPO2AL671—
In the processes of the present invention it is preferable to use those starting materials and intermediates which result in the compounds of formula (I) that are especially preferred. ;
The invention relates especially to the preparation processes described in the Exam- ples.
The invention further relates to the compounds of formula (IV) and, where applicable,
E/Z isomers, mixtures of E/Z isomers and/or tautomers, in each case in free form or in salt form. in the area of pest control, the compounds of formula (I) according to the invention are active ingredients exhibiting valuable preventive and/or curative activity with a very advant- ageous biocidal spectrum and a very broad spectrum, even at low rates of concentration, while being well tolerated by warm-blooded animals, fish and plants. They are, surprisingly, equally suitable for controlling both plant pests and ecto- and endo-parasites in humans and more especially in productive livestock, domestic animals and pets. They are effective against all or individual development stages of normally sensitive animal pests, but also of resistant animal pests, such as insects and representatives of the order Acarina, nematodes, cestodes and trematodes, while at the same time protecting useful organisms. The insecticidal or acaricidal activity of the active ingredients according to the invention may manifest itself directly, i.e. in the mortality of the pests, which occurs immediately or only after some time, for example during moulting, or indirectly, for example in reduced oviposi- : tion and/or hatching rate, good activity corresponding to a mortality of at least 50 to 60 %.
The action of the compounds according to the invention and the compositions com- prising them against animal pests can be significantly broadened and adapted to the given circumstances by the addition of other insecticides, acaricides or nematicides. Suitable additives include, for example, representatives of the following classes of active ingredient: organophosphorus compounds, nitrophenols and derivatives, formamidines, ureas, carba- mates, pyrethroids, chlorinated hydrocarbons, neonicotinoids and Bacillus thuringiensis : preparations. : : - Co
Examples of especially suitable mixing partners include: azamethiphos; chlorfenvin- phos; cypermethrin, cypermethrin high-cis; cyromazine; diafenthiuron; diazinon; dichlorvos; ) dicrotophos; dicyclanil; fenoxycarb; fluazuron; furathiocarb; isazofos; iodfenphos; kinoprene; lufenuron; methacriphos; methidathion; monocrotophos; phosphamidon; profenofos; dio- fenolan; a compound obtainable from the Bacillus thuringiensis strain GC91 or from strain
NCTC11821; pymetrozine; bromopropylate; methoprene; disulfoton; quinalphos; tau-
fluvalinate; thiocyclam; thiometon; aldicarb; azinphos-methyl; benfuracarb; bifenthrin; buprofezin; carbofuran; dibutylaminothio; cartap; chlorfluazuron; chlorpyrifos; cyfluthrin; lambda-cyhalothrin; alpha-cypermethrin; zeta-cypermethrin; deltamethrin; diflubenzuron; endosulfan; ethiofencarb; fenitrothion; fenobucarb; fenvalerate; formothion; methiocarb; hep- tenophos; imidacloprid; isoprocarb; methamidophos; methomyl; mevinphos; parathion; para- thion-methyl; phosalone; pirimicarb; propoxur; teflubenzuron; terbufos; triazamate; oo fenobucarb; tebufenozide; fipronil; beta-cyfluthrin; silafiuofen; fenpyroximate; pyridaben; fenazaquin; pyriproxyfen; pyrimidifen; nitenpyram; acetamiprid; emamectin, emamectin- benzoate; spinosad; a plant extract that is active against insects; a preparation that com- prises nematodes and is active against insects; a preparation obtainable from Bacillus sub- tilis; a preparation that comprises fungi and is active against insects; a preparation that comprises viruses and is active against insects; chlorfenapyr; acephate; acrinathrin; alany- carb; alphamethrin; amitraz; AZ 60541; azinphos A; azinphos M; azocyclotin; bendiocarb; -bensultap; beta-cyfluthrin; BPMC; brofenprox; bromophos A; bufencarb; butocarboxin; butylpyridaben; cadusafos; carbaryl; carbophenothion; chloethocarb; chiorethoxyfos; chlor- mephos; cis-resmethrin; clocythrin; clofentezine; cyanophos; cycloprothrin; cyhexatin; demeton M; demeton S; demeton-S-methyl; dichlofenthion; dicliphos; diethion; dimethoate; dimethylvinphos; dioxathion; edifenphos; esfenvalerate; ethion; ethofenprox; ethoprophos; etrimphos; fenamiphos; fenbutatin oxide; fenothiocarb; fenpropathrin; fenpyrad; fenthion;, fluazinam; flucycloxuron; flucythrinate; flufenoxuron; flufenprox; fonophos; fosthiazate; fubfenprox; HCH; hexaflumuron; hexythiazox; IKI-220; iprobenfos; isofenphos; isoxathion; ivermectin; malathion; mecarbam; mesulfenphos; metaldehyde; metolcarb; milbemectin; moxidectin; naled; NC 184; omethoate; oxamyl; oxydemethon M; oxydeprofos; permethrin; phenthoate; phorate; phosmet; phoxim; pirimiphos M; pirimiphos E; promecarb; propaphos; prothiofos; prothoate; pyrachiophos; pyradaphenthion; pyresmethrin; pyrethrum; tebufeno- zide; salithion; sebufos; sulfotep; sulprofos; tebufenpyrad; tebupirimphos; tefluthrin; teme- phos; terbam; tetrachlorvinphos; thiacloprid; thiafenox; thiodicarb; thiofanox; thionazin; thuringiensin; tralomethrin; triarthene; triazophos; triazuron; trichlorfon; triflumuron; trimetha- carb; vamidothion; xylylcarb; YI 5301/5302; zetamethrin; DPX-MP062 — indoxacarb; meth- oxyfenozide; bifenazate; XMC (3,5-xylyl methylcarbamate); or the fungus pathogen
Metarhizium anisopliae; most especially fipronil, thiamethoxam, or lambda-cyhalothrin.
The said animal pests include, for example, those mentioned in European Patent
Application EP-A-736 252, page 5, line 55, to page 6, line 55. The pests mentioned therein are therefore included by reference in the subject matter of the present invention.
—WO-03/653988- PETF/EPO2/HH671—
It is also possible to control pests of the class Nematoda using the compounds according to the invention.- Such pests include, for example, ’ root knot nematodes, cyst-forming nematodes and also stem and leaf nematodes; especially of Heterodera spp., e.g. Heterodera schachtii, Heterodora avenae and
Heterodora trifolii; Globodera spp., e.g. Globodera rostochiensis; Meloidogyne spp., e.g.
Meloidogyne incognita and Meloidogyne javanica; Radopholus spp., e.g. Radopholus similis;
Pratylenchus, e.g. Pratylenchus neglectans and Pratylenchus penetrans; Tylenchulus, e.g.
Tylenchulus semipenetrans; Longidorus, Trichodorus, Xiphinema, Ditylenchus, Apheen- choides and Anguina; especially Meloidogyne, e.g. Meloidogyne incognita, and Heterodera, e.g. Heterodera glycines.
An especially important aspect of the present invention is the use of the compounds of formula (1) according to the invention in the protection of plants against parasitic feeding pests.
The compounds according to the invention can be used to control, i.e. to inhibit or . destroy, pests of the mentioned type occurring on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forestry, or on parts of such plants, such as the fruits, blossoms, leaves, stems, tubers or roots, while in some cases plant parts that grow later are still protected against those pests.
Target crops include especially cereals, such as wheat, barley, rye, oats, rice, maize and sorghum; beet, such as sugar beet and fodder beet; fruit, e.g. pomes, stone fruit and soft fruit, such as apples, pears, plums, peaches, almonds, cherries and berries, e.g. straw- berries, raspberries and blackberries; leguminous plants, such as beans, lentils, peas and soybeans; oil plants, such as rape, mustard, poppy, olives, sunflowers, coconut, castor oil, cocoa and groundnuts; cucurbitaceae, such as marrows, cucumbers and melons; fibre plants, such as cotton, flax, hemp and jute; citrus fruits, such as oranges, lemons, grapefruit and mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes and paprika; lauraceae, such as avocado, cinnamon and camphor: and . tobacco, nuts, coffee, aubergines, sugar cane, tea, pepper, vines, hops, bananas, natural rubber plants and ornamentals.
Further areas of use of the compounds according to the invention are the protection of stored goods and storerooms and the protection of raw materials, and also in the hygiene sector, especially the protection of domestic animals and productive livestock against pests of the mentioned type, more especially the protection of domestic animals, especially cats and dogs, from infestation by fleas, ticks and nematodes. Co
The invention therefore relates also to pesticidal compositions, such as emulsifiable concentrates, suspension concentrates, directly sprayable or dilutable solutions, spreadable pastes, dilute emulsions, wettable powders, soluble powders, dispersible powders, wettable _ powders, dusts, granules and encapsulations of polymer substances, that comprise at least one of the compounds according to the invention, the choice of formulation being made in accordance with the intended objectives and the prevailing circumstances.
The active ingredient is used in those compositions in pure form, a solid active ingre- dient, for example, in a specific particle size, or preferably together with at least one of the adjuvants customary in formulation technology, such as extenders, e.g. solvents or solid carriers, or surface-active compounds (surfactants). In the area of parasite control in humans, domestic animals, productive livestock and pets it will be self-evident thai only physiologically tolerable additives are used.
As formulation adjuvants there are used, for example, solid carriers, solvents, stabilis- ] ers, “slow release” adjuvants, colourings and optionally surface-active substances (surfac- i tants). Suitable carriers and adjuvants include all substances customarily used. As adju- vants, such as solvents, solid carriers, surface-active compounds, non-ionic surfactants, cationic surfactants, anionic surfactants and further adjuvants in the compositions used according to the invention, there come into consideration, for example, those described in
EP-A-736 252, page 7, line 51 to page 8, line 39.
The compositions for use in crop protection and in humans, domestic animals and productive livestock generally comprise from 0.1 to 99 %, especially from 0.1 to 95 %, of active ingredient and from 1 to 99.9 %, especially from 5 to 99.9 %, of at least one solid or liquid adjuvant, the composition generally including from 0 to 25 %, especially from 0.1 to %, of surfactants (% = % by weight in each case). Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formula- tions having considerably lower concentrations of active ingredient.
Preferred crop protection products have especially the following compositions (% = percent by weight):
-WO-03/053988- PCTEPO2/HH671
Emulsifiable concentrates: active ingredient: 1 to 90%, preferably 5 to 20% : surfactant: 1 to 30%, preferably 10 to 20% solvent: 5 to 98%, preferably 70 to 85% )
Dusts: active ingredient: 0.1 to 10%, preferably 0.1 to 1% solid carrier: 99.9 to 90%, preferably 99.9 to 99%
Suspension concentrates: active ingredient: 5 to 75%, preferably 10 to 50% water: 94 to 24%, preferably 88 to 30% surfactant: 1 to 40%, preferably 2 to 30%
Wettable powders: active ingredient: 0.5 to 90%, preferably 1 to 80% surfactant: 0.5 to 20%, preferably 1 to 15% solid carrier: 5 to 99%, preferably 15 to 98%
Granules: active ingredient: 0.5 to 30%, preferably 3 to 15% solid carrier: 99.5 to 70%, preferably 97 to 85%
The compositions according to the invention may also comprise further solid or liquid adjuvants, such as stabilisers, e.g. vegetable oils or epoxidised vegetable oils (e.g. epoxi- dised coconut oil, rapeseed oil or soybean oil), antifoams, e.g. silicone oil, preservatives, viscosity regulators, binders and/or tackifiers as well as fertilisers or other active ingredients for obtaining special effects, e.g. acaricides, bactericides, fungicides, nematicides, mollus- cicides or selective herbicides.
The crop protection products according to the invention are prepared in known manner, in the absence of adjuvants, e.g. by grinding, sieving and/or compressing a solid active ingredient or mixture of active ingredients, for example to a certain particle size, and in the presence of at least one adjuvant, for example by intimately mixing and/or grinding the active ingredient or mixture of active ingredients with the adjuvant(s). The invention relates likewise to those processes for the preparation of the compositions according to the invention and to the use of the compounds of formula (1) in the preparation of those compo- : sitions.
The invention relates also to the methods of application of the crop protection prod- ucts, i.e. the methods of controlling pests of the mentioned type, such as spraying, atomis- . _ing, dusting, coating, dressing, scattering or pouring, which are selected in accordance with. the intended objectives and the prevailing circumstances, and to the use of the compositions for controlling pests of the mentioned type. Typical rates of concentration are from 0.1 to 1000 ppm, preferably from 0.1 to 500 ppm, of active ingredient. The rates of application per hectare are generally from 1 to 2000 g of active ingredient per hectare, especially from 10 to 1000 g/ha, preferably from 20 to 600 g/ha.
A preferred method of application in the area of crop protection is application to the foliage of the plants (foliar application), the frequency and the rate of application being dependent upon the risk of infestation by the pest in question. However, the active ingredient . can also penetrate the plants through the roots (systemic action) when the iocus of the plants is impregnated with a liquid formulation or when the active ingredient is incorporated in solid form into the locus of the plants, for example into the soil, e.g. in granular form (soil application). In the case of paddy rice crops, such granules may be applied in metered amounts to the flooded rice field. )
The crop protection products according to the invention are also suitable for protecting plant propagation material, e.g. seed, such as fruits, tubers or grains, or plant cuttings, against animal pests. The propagation material can be treated with the composition before planting: seed, for example, can be dressed before being sown. The active ingredients according to the invention can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation. The composition can also be applied to the planting site when the propagation material is being planted, for example to the seed furrow during sowing. The invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated. } Preparation Examples
In the following Examples, the preparation of avermectin B1 derivatives (mixtures of avermectin Bla and B1b derivative) is described. The B1b derivative generally represents
WO-031053988 PCHEPO2/H671 about only from 5 to 10 % by weight of the mixtures and, for that reason, usually only the bands of the B1a derivative can be detected in the NMR spectrum. :
Since the compounds are in most cases in the form of mixtures of the avermectin Bia and B1b derivative, characterisation by means of the customary physical data such as melting point or refractive index is of little use. For that reason, - the compounds are charac- terised by means of NMR spectroscopy following purification by chromatography, or by reference to the retention times determined in analysis by means of HPLC (high-resolution liguid chromatography). The term “Bia” in the physical data on the Preparation Examples refers to the main component, wherein R; is sec-butyl. “B1b” represents the secondary : component, wherein R; is isopropyl. In the case of the compounds for which a retention time is given only for the B1a derivative, it is not possible to determine the retention time for the
B1b component owing to the small proportion of B1b derivative. Allocation of the correct structures of the B1a and B1b components is carried out by mass spectrometry.
The following method is used for the HPLC analysis:
HPLC gradient conditions solvent A: 0.01% trifluoroacetic acid in HO solvent B: 0.01% trifluoroacetic acid in CH;CN time [min] A [%] B [%] flow rate [ul/min] 0 80 | 20 500 0.1 } 50 50 500 5 95 500 0 100 500 17 0 100 500 171 80 20 | 500 oo oo 22 80 20 500 ' column: YMC-Pack ODS-AQ column length: 125 mm column internal diameter: 2 mm temperature: 40 °C
The YMC-Pack ODS-AQ column used for chromatography of the compounds is pro- duced by YMC, Alte Raesfelderstrasse 6, 46514 Schermbeck, Germany.
The abbreviations used in the physical data information have the following meanings: s: singlet, MHz: megahertz, brs: broad singlet; t: triplet; m: multiplet; d: doublet;
J: coupling constant; bd: broad doublet; LCMS: liquid chromatography mass spectrometry; try: retention time in minutes; M+H: mass peak plus H; M+Na: mass peak plus Na. TBDMS in the Examples represents the radical -Si(CHz)o(tert-butyl). Mixing ratios of solvents are given in parts by volume. “Ether” is understood to mean diethyl ether. :
Example P.1: Preparation of 4"-sulfamoyloxy-avermectin B, 7
HN 4 =, Jo) o” 0” "0, 0), 7 ot 070, JN lo) -
Cd Og O
Ng ot: lo}
OH
Preparation of sulfamoyl chloride (CISO.NH,): 15.5 mi of formic acid are added drop- wise at -10°C to 35 mi of chlorosulfonyl isocyanate and the temperature is maintained below +10°C by cooling with ice. At the end of the addition, stirring is continued at room tempera- ture until the evolution of gas ceases. The mixture is taken up in benzene, filtered, and con- centrated by evaporation in vacuo, yielding the desired sulfamoyl chloride.
Step A: 3.51 g of sulfamoyl chloride are added in portions at -10°C to a solution of 15 g of 5-O-TBDMS-avermectin B; in 90 ml of dimethylacetamide under argon. The mixture is allowed to warm to room temperature and is stirred for a further hour. The mixture is poured onto saturated aqueous NaCl solution, extracted twice with tert-butyl methyl ether, dried over
Na,SO, and concentrated by evaporation, yielding the desired intermediate 5-O-TBDMS-4"-
O-sulfamoyloxy-avermectin B,.
Step B: The crude product from Step A is dissolved in 75 ml of methanol. Then, at ~~ -5°C, 1.5 ml of methanesulfonic acid in 75 ml of methanol are added dropwise in the course
WO-03/053988 PCTHEPO2/I4671 of one hour. The mixture is allowed to warm to room temperature and is left to react for four hours. The solution is poured onto saturated aqueous NaHCO; solution, concentrated by § evaporation in vacuo, and extracted twice with tert-butyl methyl ether. Washing with satu- rated aqueous NaCl solution, drying over Na,SO, and concentration by evaporation yield the ; crude product. Flash column chromatography on silica gel in CH,Cl,/ethy! acetate (9:1) yields the desired product in the form of a colourless foam. 4"-Sulfamoyloxy-avermectin B; : C4H73NO46S, molecular weight: 951.5. LCMS: fxr,
Bia: 9.08 min., 974.5 (M+Na), 952.5 (M+H), By: 8.44 min.; NMR (250 MHz, CDCl,) selected data, 8H (ppm): 1.48 (s, 3H, CHs-14a), 1.86 (s, 3H, CHj-4a), 3.21 (t, 1H, J = 9.2 Hz, CH-4)), 3.28 (m, 1H, CH-2), 3.40 (s, 3H, OCH), 3.42 (s, 3H, OCHj), 3.95 (d, 1H, J = 6.4 Hz, CH-6), 4.05 (s, 1H, HO-C-7), 4.14 (t, 1H, J = 9.6 Hz, CH-4"), 4.28 (m, 1H, CH-5), 4.67 (m, 2H, CH,- 8a), 4.76 (d, 1H, J = 2.75 Hz, CH-1), 4.96 (m, 1H, CH-15), 5.10 (brs, 2H, H,NSO,0C-4").
Example P.2: Preparation of 4"-methylaminosuifonyloxy-avermectin B1
J ve
HN vO, o=8 pd 30) 9 o”"o, 0), AN
O° "0, AR 0. “5
Og ©
Il oH: 0}
OH
Preparation of N-methylsulfamoyl chloride (CISO.NHMe): 16.9 g of methylamine hydrochloride in 80 ml of acetonitrile are added to a solution of 65 ml of sulfuryl chloride in 50 ml of acetonitrile. After 24 hours at 60°C, the reaction mixture is cooled to room tem- perature, filtered off and concentrated by evaporation. Vacuum distillation of the resulting brownroil yields the desired product in the form of a colourless oil. oo
Step A: 240 mg of N-methylsulfamoyl chloride are added at 0°C to a solution of 400 mg of 5-O-TBDMS-avermectin B, in 5 mi of dimethylacetamide under argon, and the p mixture is left to react at room temperature for 2 hours. The mixture is poured onto saturated
NaCl solution, extracted twice with ethyl acetate, dried over Na,SO, and concentrated by evaporation, yielding the desired intermediate 5-O-TBDMS-4"-O-(N-methyl)-sulfamoyloxy-
avermectin B.
Step B: 1 ml of HF-pyridine reagent (25 g of commercial 70 % HF-pyridine solution, 27.5 ml of tetrahydrofuran, 12.5 ml of pyridine) is added to a solution of the resulting crude product in 5 ml of absolute tetrahydrofuran and the mixture is left to stand at room tempera- ture for 12 hours. The reaction mixture is poured onto water and is extracted twice with : ether. Washing with saturated NaHCO; solution, drying over Na,SO, and concentration by evaporation yield the crude product. Flash column chromatography on silica gel in hexane/ethyl acetate (1:1) yields the desired product in the form of a colourless foam. 4"-Methylaminosulfonyloxy-avermectin B1: C4H;sNO46S, molecular weight: 965.5.
LCMS: trr, Bia: 9.88 min., 988.3 (M+Na), 966.6 (M+H), Bip: 9.24 min.; NMR (300 MHz,
CDCI;) selected data, 8H (ppm): 1.48 (s, 3H, CH;-14a), 1.86 (s, 3H, CHs-4a), 2.80 (d, 3H,
J = 5.5 Hz, H;CNHSO.,0C-4"), 3.21 (1, 1H, J =9.2 Hz, CH-4), 3.28 (m, 1H, CH-2), 3.40 (s, 3H, OCHj3), 3.42 (s, 3H, OCHa), 3.95 (d, 1H, J=6.4 Hz, CH-6), 4.08 (t, 1H, J = 9.1 Hz,
CH-4"), 4.28 (m, 1H, CH-5), 4.67 (m, 2H, CH-8a), 4.76 (d, 1H, J = 2.75 Hz, CH-1’), 4.78 (q, 1H, J = 5.5 Hz, HN(CH3)S0O,0C-4"), 4.96 (m, 1H, CH-15).
Example P.3: Preparation of 4"-ethylaminosulfonyloxy-avermectin B,
Yo
HN by 0,
X10, . A 0” "0, 0) “0
Cd 0x0 x
I| oH: lo!
OH
Preparation of N-ethylsulfamoyl chloride (CISO.NHEt): 16.9 g of ethylamine hydro- ) chloride are added to a solution of 7.3 ml of sulfuryl chloride in 15 ml of acetonitrile. After stirring for 12 hours at the reflux temperature of the mixture, the reaction mass is cooled to ) room temperature, filtered off and concentrated by evaporation. Vacuum distillation (0.05 mm, 100°C) of the resulting residue yields the desired product in the form of a colourless oil.
Step A: 240 mg of N-methylsulfamoyl chloride are added at 0°C to a solution of
—WO-03/053988 PETEPO2AH671 400 mg of 5-O-TBDMS-avermectin B, in 5 ml of dimethylacetamide under argon, and the mixture is left to react at room temperature for 12 hours. The mixture is poured onto satu- : rated NaCl solution, extracted twice with ethyl acetate, dried over Na,SO, and concentrated by evaporation, yielding the desired intermediate 5-O-TBDMS-4"-O-(N-methyl)-sulfamoyloxy- ' avermectin B;.
Step B: 0.2 ml of methanesulfonic acid is added at 0°C to a solution of the crude product obtained in Step A in 1.5 ml of methanol and the mixture is left to react at room temperature for 20 minutes. The reaction mixture is poured onto saturated NaHCO; solution, concentrated by evaporation, extracted with ethyl acetate, subsequently washed with saturated NaCl solution, dried over Na,SO, and concentrated by evaporation. Flash column chromatography of the crude product on silica gel in hexane/ethyl acetate (1:1) yields the desired product in the form of a yellow foam. 4"-Ethylaminosulfonyloxy-avermectin By: CsoH77NO4S, molecular weight: 979. LCMS: ter, Bia: 10.25 min., 1002.2 (M+Na), 980.5 (M+H), Bp: 9.56 min.; NMR (300 MHz, CDCl,) selected data, 8H (ppm): 1.21 (t, 3H, J = 7.3 Hz, H;CCH,), 1.48 (s, 3H, CH3s-14a), 1.86 (s, 3H, CHs-4a), 2.80 (d, 3H, J = 5.5 Hz, H;,CNHS0,0C-4"), 3.39 (s, 3H, OCH), 3.42 (s, 3H,
OCH), 3.96 (d, 1H, J = 5.9 Hz, CH-6), 4.10 (i, 1H, J = 9.1 Hz, CH-4"), 4.28 (m, 1H, CH-5), 4.68 (m, 2H, CH,-8a), 4.73 (t, 1H, J = 4.6 Hz, HN(CH,CH;)S0O,0C-4"), 4.96 (m, 1H, CH-15).
Example P.4: Preparation of 4"-allylaminosulfonyloxy-avermectin B, ¢ _
HN vO, o=% ~ 0 ™ 7 0” “0, ie) AN 0770, o . “Oo
Co Ox 0
Xx oo So Co dpoH:. - li . O .
OH
A solution of 238 mg of 4"-sulfamoyloxy-avermectin B1, 138 mg of potassium carbon- ate and 0.1 ml of allyl bromide in 5 ml of acetonitrile is stirred at room temperature for hours. The solution is poured onto water, extracted with ether and dried over Na,SO,4. The desired product is isolated from the crude mixture by column chromatography on silica gelin hexane/ethyl acetate (65:35). 4"-Allylaminosulfonyloxy-avermectin B,: Cs1H;7NO4¢S, molecular weight: 991.5. LCMS: try, Bia: 9.87 min., 1014.5 (M+Na), 992.5 (M+H), B,,: 9.28 min.; NMR (300 MHz, CDCls) selected data, SH (ppm): 1.48 (s, 3H, CHs-14a), 1.86 (s, 3H, CHs-4a), 3.21 (i, 1H, J=9.2 Hz, oo CH-4%),-3.29 (m, 1H, CH-2), 3.36(s,-3H, OCHs),-3.42(s,-3H,. OCH), 3.96 (d, 1H, J = 6.4 Hz,
CH-6), 4.13 (t, 1H, J = 9.6 Hz, CH-4"), 4.28 (m, 1H, CH-5), 4.67 (m, 2H, CH.-8a), 4.77 (d, 1H, J = 2.8 Hz, CH-1%), 4.90 (dd, 1H, J = 7.8, 4.6 Hz, HNSO,0C-4"), 4.96 (m, 1H, CH-15), 5.20 (dd, 1H, J = 10.5, 1.4 Hz, H,.C=CH), 5.28 (dd, 1H, J = 16.9, 1.4 Hz, H,C=CH).
Example P.5: Preparation of 4”-diallylaminosulfonyloxy-avermectin B, 4 =U
N vO, 0=% - (6) Jo! { 0” “0, 1), = ot oO” "0, A O. “5
Cd Os 0 x
Il_oH: lo]
OH
A solution of 238 mg of 4”-sulfamoyloxy-avermectin B1, 138 mg of potassium carbon- ate and 0.1 ml of allyl bromide in 5 mi of acetonitrile is stirred at reflux for 1 hour. The solu- tion is poured onto water, extracted with ether and dried over Na;SO,. Concentration by evaporation yields the title product. 4"-Diallylaminosulfonyloxy-avermectin B;: CsHgiNO46S, molecular weight: 1031.5.
LCMS: tg7, Bia: 11.47 min., 1054.5 (M+Na), 1032.5 (M+H), By: 10.89 min.; NMR (300 MHz,
CDCl) selected data, 8H (ppm): 1.48 (s, 3H, CHs-14a), 1.86 (s, 3H, CH;-4a), 3.21 (t, 1H, J = ] 9.2 Hz, CH-4’), 3.29 (m, 1H, CH-2), 3.43 (s, 3H, OCHj3), 3.48 (s, 3H, OCHj3), 3.96 (d, 1H, J = 6.4 Hz, CH-6), 4.13 (t, 1H, J = 9.1 Hz, CH-4"), 4.28 (m, 1H, CH-5), 4.67 (m, 2H, CH»-8a), 4.75 (m, 1H, CH-1’), 4.96 (m, 1H, CH-15).
WO-03/053988— ~PET/EPO2/H4671
Example P.6: 4"-(2-Hydroxyethylaminosulfonyloxy)-avermectin B,
OH ) §
HN . vO, 0o=8 - ! I. ’ oo, 0) AN 07 "0, AN lo) -.
Co Os 0 x l| oH: o}
OH
A solution of 238 mg of 4"-sulfamoyloxy-avermectin B1, 138 mg of potassium carbon- ate and 0.1 ml of 2-bromoethanol in 5 mi of acetonitrile is stirred at reflux for 12 hours. The solution is poured onto water, extracted with ether and dried over Na,SO,. The title product is isolated from the crude mixture by column chromatography on silica gel in hexane/ethyl acetate (30:70). 4"-(2-Hydroxyethylaminosulfonyloxy)-avermectin By: CsoH;7NO47S, molecular weight: 995.5. LCMS: try, Bia: 8.43 min., 1018.45 (M+Na), 996.5 (M+H), By: 7.79 min.; NMR (250 MHz, CDCl;) selected data, 8H (ppm): 1.17 (t, 3H, J = 6.9 Hz, H,COH}), 1.48 (s, 3H,
CHa-14a), 1.86 (s, 3H, CHs-4a), 3.21 (t, 1H, J = 9.1 Hz, CH-4), 3.28 (m, 1H, CH-2), 3.31 (m, 2H, H.CNH), 3.41 (s, 3H, OCH), 3.42 (s, 3H, OCH,), 3.96 (d, 1H, J = 6.4 Hz, CH-6), 4.14 (i, 1H, J = 9.1 Hz, CH-4"), 4.29 (m, 1H, CH-5), 4.67 (m, 2H, CH>-8a), 4.76 (d, 1H, J = 3.2 Hz,
CH-1’), 4.96 (m, 1H, CH-15), 5.23 (dd, 1H, J = 6.9, 5.5 Hz, HNSO,0C-4").
Example P.7: Preparation of 4"-dimethylaminosulfonyloxy-avermectin B, ~y 3 0” =S"" 0” "“o,, . 0), AN oO" "0, xg 0) "5
Co OO
Xx oH: o}
OH
A solution of 238 mg of 4"-sulfamoyloxy-avermectin B1, 138 mg of potassium carbon- . ate and 0.1 ml of iodomethane in 5 ml of acetonitrile is stirred at reflux for 5 hours. The solution is poured onto water, extracted with ether and dried over Na,SO,. The title product : is isolated from the crude mixture by column chromatography on silica gel in hexane/ethyl acetate (1:1). 4"-Dimethylaminosulfonyloxy-avermectin B;: CsoH77NO46S, molecular weight: 979.5.
LCMS: try, Bia: 10.69 min., 1002.5 (M+Na); NMR (300 MHz, CDCl) selected data, 8H (ppm): 1.48 (s, 3H, CHz-14a), 1.87 (s, 3H, CHz-4a), 2.91 (s, 6H, (HsC):N), 3.21 (t, 1H, J = 9.1 Hz,
CH-4’), 3.28 (m, 1H, CH-2), 3.40 (s, 3H, OCH,), 3.43 (s, 3H, OCH), 3.96 (d, 1H, J = 6.4 Hz,
CH-6), 4.08 (1, 1H, J = 9.1 Hz, HC-4"), 4.68 (m, 2H, CH,-8a), 4.76 (bd, 1H, J = 2.8 Hz, CH- 1’), 4.96 (m, 1H, CH-15).
Example P.8: Preparation of 4"-dipropargylaminosulfonyloxy-avermectin B, \ t o~ se o=§ 0” o ’y 0” "0, je! ye 0770, JI 0) “0
Cd Os O x oH: lo!
OH
A solution of 238 mg of 4"-sulfamoyloxy-avermectin B1, 138 mg of potassium carbon- ate and 0.14 ml of propargyl bromide (80 % in toluene) in 5 ml of acetonitrile is stirred at room temperature for 18 hours. The solution is poured onto water, extracted with ether and dried over Na;SO,. The desired product is isolated from the crude mixture by column chromatography on silica gel in hexane/ethyl acetate (65:35). 4"-Dipropargylaminosulfonyloxy-avermectin B,: CssH77NO46S, molecular weight: 1027.5. LCMS: ter, Bia: 10.62 min., 1050.4 (M+Na), 1028.5 (M+H), By: 9.98 min.; NMR (250 MHz, CDCls) selected data, 8H (ppm): 1.48 (s, 3H, CHs-14a), 1.86 (s, 3H, CHs-4a), 2.34 (t, 2H, J=2.3 Hz, HCCCH,), 3.20 (t, 1H, J = 8.7 Hz, CH-4’), 3.28 (m, 1H, CH-2), 3.40 (s, 3H,
OCH), 3.42 (s, 3H, OCH3), 3.96 (d, 1H, J = 5.9 Hz, CH-6), 4.23 (ABX System, 4H, J = 17.8,
WO-03053988 PCHEPO2L 67 2.9 Hz, H,CNHSO,0C-4"), 4.67 (m, 2H, CH,-8a), 4.76 (bd, 1H, J = 3.2 Hz, CH-1’), 4.96 (m, 1H, CH-15). .
Example P.9: Preparation of 4"-bis(cyanomethyl)aminosulionyloxy-avermectin B,
N\
N se 0=% oo” . AN 0” “0, lo) “5 :
Co OO xy ot 0
OH
A solution of 238 mg of 4"-sulfamoyloxy-avermectin B1, 138 mg of potassium carbon- ate and 0.09 mi of bromoacetonitrile in 5 ml of acetonitrile is stirred at room temperature for hours. The solution is poured onto water, extracted with ether and dried over Na,SO,..
The desired product is isolated from the crude mixture by column chromatography on silica : gel in hexane/ethyl acetate (60:40). 4"-Dicyanomethylaminosulfonyloxy-avermectin By: CsaH7sN3046S, molecular weight: 1029.5. LCMS: tzr, Bya: 9.88 min., 1052.4 (M+Na), 1030.5 (M+H), By: 9.29 min.; NMR (250 MHz, CDCl) selected data, 8H (ppm): 1.48 (s, 3H, CHs-14a), 1.86 (s, 3H, CHs-4a), 3.19 (t, 1H, J = 8.7 Hz, CH-4’), 3.28 (m, 1H, CH-2), 3.40 (s, 3H, OCH), 3.42 (s, 3H, OCHa), 3.96 (d, 1H, J = 6.4 Hz, CH-6), 4.22 (t, 1H, J = 9.1 Hz, CH-4"), 4.38 (AB system, 4H, J = 18.3 Hz,
H,CCN), 4.67 (m, 2H, CH,-8a), 4.76 (bd, 1H, J = 3.2-Hz, CH-1’), 4.96 (m, 1H, CH-15).
Example P.10: Preparation of 4"-pyrrolidinosulfonyloxy-avermectin B1
Ly ¢
N
‘ 250 o”
Oo ’ o”"o,, 0” 0, A 0 “o
Cl OO x ok:
OH
A solution of 238 mg of 4"-sulfamoyloxy-avermectin B1, 138 mg of potassium carbon- ate and 0.15 ml of 1,4-dibromobutane in 5 ml of acetonitrile is stirred at reflux for 12 hours.
The solution is poured onto water, extracted with ether and dried over Na,SO,. The desired product is isolated from the crude mixture by column chromatography on silica gel in hex- ane/ethyl acetate (60:40). : 4"-Pyrrolidinosulfonyloxy-avermectin By: CsoHzoNO46S, molecular weight: 1005.5.
LCMS: try, Bia: 10.67 min., 1028.5 (M+Na), 1006.5 (M+H), By: 10.03 min.; NMR (250 MHz,
CDCl) selected data, 8H (ppm): 1.48 (s, 3H, CHj3-14a), 1.86 (s, 3H, CHs-4a), 3.21 (1, 1H, J = 8.7 Hz, CH-4’), 3.28 (m, 1H, CH-2)}-3.38 (s, 3H, OCHj3), 3.42 (s, 3H, OCHj3), 3.96 (d, 1H, J = 5.9 Hz, CH-6), 4.28 (m, 1H, HC-5), 4.67 (m, 2H, CH.-8a), 4.76 (bd, 1H, J = 3.2 Hz, CH-1), 4.96 (m, 1H, CH-15).
Example P.11: Preparation of 4"-benzoylaminosulfonyloxy-avermectin B, fo}
Or -
N vO, 0=S ’ pe . 0 Jo) 9 0” “0, 1), “= ot - 0” "0, 0) “0
Cl 0:0 : : Xx oH: 0!
OH .
-WO-03/053988 PCTEPO2A4671—
A mixture of 200 mg of 4"-sulfamoyloxy-avermectin Bs, 0.15 ml of benzoyl chloride in 3 mi of ethyl acetate and 3 ml of saturated aqueous NaHCO; solution is stirred at 70°C for : 6 hours. The mixture is poured onto water, extracted with ether and dried over Na,SO,. The desired product is isolated from the crude mixture by column chromatography on silica gel in ' hexane/ethyl acetate (1:1). 4"-Benzoylaminosulfonyloxy-avermectin Bi: CssH77NO47S, molecular weight: 1055.5.
LCMS: try, Bia: 9.83 min., 1078.4 (M+Na), 1056.5 (M+H), Byp: 9.18 min.
Example P.12: Preparation of 4"-epi-sulfamoyloxy-avermectin B1 of the formula
HN 0” ’5° ps .
SY
0” "0, ’ 58) ~~ - 07 "0, lo) “5
Co OO x
I| oH: o
OH
50 mg of sulfamoyl chloride are added at 0°C to a solution of 197 mg of 4"-epi-5-O-
TBDMS-avermectin B; (0.2 mmol) in 3 ml of dimethylacetamide under argon, and the mix- ture is left to react at room temperature for 3 hours. The mixture is poured onto cold-satu- rated NaCl solution, extracted twice with ethyl acetate, dried over Na,SO, and concentrated by evaporation, yielding 5-O-TBDMS-4"-epi-sulfamoyloxy-avermectin B;. 1 ml of. HF-pyridine reagent (25 g of 70 % HF-pyridine solution, 27.5 mi of tetrahydro- furan, 12.5 ml of pyridine) is added to a solution of 5-O-TBDMS-4"-epi-sulfamoyloxy-aver- mectin B; in 5 ml of absolute tetrahydrofuran and the mixture is left to stand at room tem- perature for 12 hours. The reaction mixture is poured onto water and extracted twice with ether. Washing with saturated NaHCO; solution, drying over Na,SO, and concentration by oo evaporation yield the crude product. Flash column chromatography on silica gel in hexane/ethyl acetate (1:1) yields the desired product. 4"-epi-Sulfamoyloxy-avermectin B1: C4sH73NO46S, molecular weight: 951.5. LCMS: tz,
Bia: 9.13 min., 974.5 (M+Na), 952.5 (M+H), Bip: 8.49 min.
The compounds listed in Table A and in Tables 1 to 6 can also be prepared analo-
gously to the above Preparation Examples.
Table A: Compounds of formula
R2 ~~
A3—N q
Nr On, 1) CF lo) ... 0” "o,, 23 0) 2 2 ZN" o” "o, 0 ,, XX 25 0” >r1 (la) 0.__0O xX : | on: lo}
OH or of formula
R2 _
R3—N Y \ Oo o=7 O) 0” lo) .., 0” "o,, 23 0). a o” “o, 0 1, RN 25 0" >r1 (Ib) 0.__0O x ou: 0] — Oh wherein R; is sec-butyl (B1a) or isopropyl (B1b) and R; is hydrogen: retention time (min.)
No. formula R; Rs
P.1 la H H 9.08 8.44 . P.2 la H CHa; 9.88 9.24
P.3 la H CH,CHg 10.25 9.56
P.4 la H allyl 9.47 9.28
P.5 la allyl allyl 11.47 10.89
—WO-03/053988— —PCTHEPO2146H B retention time (min.)
No. formula R. Rs
P.6 la H ~ CH,CH.OH 8.43 7.77
P.7 la CHs CH, 10.69
P.8 la propargyl propargyl 10.62 9.98
P.9 fa CH.CN CH,CN 9.88 9.29
P.10 la -CH,CH,CH,CH,- 10.67 10.08
P.11 la H C(O)Ph 9.83 9.18
P.12 Ib H H 9.13 8.49
P.13 la H C(O)isoPr 9.65 8.98
P.14 la H C(O)Me 9.12 8.43
P.15 la H C(O)Et 9.28 8.54
P.16 la H C(O)cyclopropyl 9.44 8.80
P.17 la H C(O)OCH; 9.55 8.91
Table B: Compounds of formula (I):
No. retention time (min.)
B.1 isopropyl
B.2 ~ propyl :
B.3 n-butyl
B.4 sec-butyl
B.5 isobutyl
B.6 tert-butyl
B.7 CH(CH3)CH(CH:),
B.8 CH(CH,CH,)CH,C!
B.9 CH(CH3)CH,OCHj,
B.10 2-chloro-propyl an oo
B.11 3-chloro-propyl
B.12 2-chloro-ethyl }
B.13 CH,CH,OCH;
B.14 2-fluoro-ethyl
B.15 2-morpholino-ethyl retention time (min.)
No. Ra
B.16 2-pyrrolidino-ethyl
B.17 cyclopropyl ~~ BaA8 | ~~ cyclobutyl I So
B.19 cyclopentyl
B.20 cyclohexyl
B.21 bis(trifluoromethylymethyl
B.22 benzyl
B.23 2-methylallyl
B.24 3-methylallyl
B.25 CH,C(O)OCH;
B.26 CH,CH,C(O)OCH,
B.27 2-phthalimido-ethyl
B.28 2-aminoethyi
B.29 2-methylaminoethyl
B.30 2-dimethylaminoethyl
B.31 CH,CH,OC Hs
B.32 CH,CH,OCH,CH,OCHjs
B.33 3-phthalimido-propyl
B.34 4-phthalimido-butyl
B.35 CH,CONH,
B.36 CH,COOH
B.37 (2-fluorophenyl)methyl
B.38 (3-fluorophenyl)methyl
B.39 (2,6-difluorophenyl)methyl
B.40 (4-fluorophenyl)methyl
B.41 (4-trifluoromethylphenyl)methyl
B.42 ow ox
B.43 (4-trifluoromethoxyphenyl)ymethyl
B.44 (4-difluoromethylphenyl)methyl
WO-03/053988- PCT/EP02/14671- retention time (min.)
No. Ra . N : \ IN
B.45 “O . =
NN
B.46 ¥Z y NN
B.47 ~N . 0.
B.48 TL 5.45 TOL . xy
B.50 (4-methoxyphenylymethyl
Table 1: A compound of formula (la) wherein R; is sec-butyl (B1a) or isopropyl (B1b), Rs is hydrogen and R; corresponds to one of the radicals of Table B listed under B.1 to B.50.
Table 2: A compound of formula (Ib) wherein R; is sec-butyl (B1a) or isopropyl (B1b), Rs is hydrogen and R. corresponds to one of the radicals of Table B listed under B.1 to B.50.
Table C: Compounds of formula (I) retention time (min.)
No.
C.001 isopropyl
C.002 propyl
C.003 Fa. n-butyl —- - . . Le
C.004 sec-butyl
C.005 isobutyl
C.006 tert-butyl
C.o07 methyl
C.008 ethyl
No. retention time (min.)
C.009 vinyl
C.010 2-chloro-propyl __ _. Cont _| 3-chiloro-propyl SI
C.012 2-chloro-ethy!
C.013 CH,CH,OCHj5
C.014 allyl
C.015 CH,OCH;,
C.016 CHLOpReny
C.017 cyclopropyl
C.018 cyclopentyl
C.019 cyclohexyl
C.020 CH>CH,NH,
C.021 benzyl
C.022 fluoromethyl
C.023 difluoromethyl
C.024 . S
C.025 LoS \ lw N
N
C.026 CH,OCH,CH.Ome
C.027 OCHjs >028 OCH,CH;3
C.029 O-allyl
C.030 OCH,CH-OH
C.031 NH, , C.032 NHCH3;
C.033 N(CHa) . C.034 benzyl :
Table 3: A compound of formula (la) wherein R; is sec-butyl (B1a) or isopropyl (B1b), Raz is
C(=0)R; and Rs is hydrogen, and R, corresponds to one of the radicals of Table C listed under C.1 to C.034.
WO-03/053988- PCHEPO2/1H46H
Table 4: A compound of formula (Ib) wherein R; is sec-butyl (B1a) or isopropyl (B1 b}), Rs is -C(=0)R, and Rj is hydrogen, and R, corresponds to one of the radicals of Table C listed : under C.1 to C.034.
Table D: Compounds of formula (I) retention time (min.)
No. R.
D.001 -CH,CH-
D.002 -CH,CH,CH,-
D.003 -CH,(CH,);CH.-
D.004 -CH,CH,OCH,CH.-
D.005 ethyl ethyl
D.006 ethyl methyl
D.007 allyl methyl
D.009 C(O)CHg methyl
D.010 C(O)OCHj4 methyl
D.o11 C(O)Ph methyl
D.012 SO,NH, H
D.013 SO,NMe, H
D.014 =N"=N
D.015 benzyl benzyl
D.016 TL \ TL o 0) er Ne
F F
D.017 | (4-methoxyphenyl)methyl (4-methoxyphenylmethyl
Table 5: A compound of formula (1a) wherein R; is sec-butyl (Bla) or isopropyl (B1b), and R, oo and R; correspond to one of the radicals of Table D listed under D.1 to D.016.
Table 6: A compound of formula (ib) wherein R; is sec-butyl (B1a) or isopropyl! (Bib), and R» ’ and R; correspond to one of the radicals of Table D listed under D.1 to D.016.
Formulation Examples for use in crop protection (% = percent by weight)
Example F1: Emulsifiable concentrates a) b) Cc) active ingredient 25% 40% 50% calcium dodecylbenzenesuifonate 5% 8% 6% castor oil polyethylene glycol ether (36 mol EO) 5% - - tributylphenol polyethylene glycol ether (30 mol EO) - 12% 4% cyclohexanone - 15% 20% xylene mixture 65% 25% 20%
Mixing finely ground active ingredient and additives gives an emulsifiable concentrate which yields emulsions of the desired concentration on dilution with water.
Example F2: Solutions a) b) Cc) d) active ingredient 80% 10% , 5% 95% ethylene glycol monomethyl ether 20% - - polyethylene glycol (MW 400) - 70% -
N-methylpyrrolid-2-one 20% - - - epoxidised coconut oil - - - 1% benzine (boiling range: 160-190°) - - 94% -
Mixing finely ground active ingredient and additives gives a solution suitable for use in the form of microdrops.
Example F3: Granules a) b) Cc) d) active ingredient 5% 10% 8% 21% kaolin 94% - 79% 54% highly dispersed silicic acid 1% - 13% 7% attapulgite - 90% - 18%
The active ingredient is dissolved in dichloromethane, the solution is sprayed onto the carrier mixture and the solvent is evaporated off in vacuo.
WO-03/6053988 PCTHEPO214671
Example F4: Wettable powders a) b) Cc) active ingredient 25% 50% 75% - sodium lignosulfonate 5% 5% - sodium lauryl sulfate 3% - 5% ‘ sodium diisobutylnaphthalenesulfonate - 6% 10% octylphenol polyethylene glycol ether (7-8 mol EO) - 2% - highly dispersed silicic acid 5% 10% 10% kaolin 62% 27% -
Active ingredient and additives are mixed together and the mixture is ground in a suitable mill, yielding wettable powders that can be diluted with water to form suspensions of the desired concentration.
Example F5: Emulsifiable concentrate active ingredient 10% : octylphenol polyethylene glycol ether (4-5 mol EO) 3% calcium dodecylbenzenesuifonate 3% castor oil polyethylene glycol ether (36 mol EO) 4% cyclohexanone 30% xylene mixture 50%
Mixing finely ground active ingredient and additives gives an emulsifiable concentrate which yields emulsions of the desired concentration on dilution with water.
Example F6: Extruder granules active ingredient 10% sodium lignosulfonate 2% carboxymethylcellulose 1% kaolin 87%
Active ingredient and additives are mixed together, the mixture is ground, moistened with water, extruded and granulated and the granules are dried in a stream of air. ~ -- -
Example F7: Coated granules active ingredient 3% . polyethylene glycol (MW 200) 3% kaolin 94%
Uniform application of the finely ground active ingredient to the kaolin moistened with poly- ethylene glycol in a mixer yields non-dusty coated granules.
Example F8: Suspension concentrate active ingredient 40% ethylene-glycol 10% nonylphenol polyethylene glycol ether (15 mol EQ) 6% sodium lignosulfonate 10% carboxymethylcellulose 1% aqueous formaldehyde solution (37%) 0.2% aqueous silicone oil emulsion (75%) 0.8% water 32%
Mixing finely ground active ingredient and additives gives a suspension concentrate which yields suspensions of the desired concentration on dilution with water.
Biological Examples:
Example B1: Action against Spodoptera littoralis
Young soybean plants are sprayed with an aqueous emulsion spray mixture comprising 12.5 ppm of test compound and, after the spray-coating has dried, the plants are populated with 10 caterpillars of Spodoptera littoralis in the first stage and then placed in a plastics container. 3 days later, the percentage reduction in population and the percentage reduction in feeding damage (% activity) are determined by comparing the number of dead caterpillars and the feeding damage on the treated plants with that on untreated plants.
Compounds P.1 10 P.11 and of Tables 1 to 3 exhibit good activity in this test. In particular. compounds P.1 and P.2 are more than 80 % effective.
Example B2: Action against Spodoptera littoralis, systemic:
Maize seedlings are placed in the test solution. 6 days later, the leaves are cut off, placed on moist filter paper in a petri dish and infested with 12 to 15 Spodoptera littoralis larvae in the L; stage. 4 days later, the percentage reduction in population (% activity) is determined by comparing the number of dead caterpillars on treated plants with that on untreated plants.
Compounds P.1 to P.11 and of Tables 1 to 3 exhibit good activity in this test. In particular,
P.1 and P.2 are more than 80 % effective.
“WO-03/053988— POHEPOIH6TH
S42
Example B3: Action against Heliothis virescens 30-35 eggs of Heliothis virescens, from 0 to 24 hours old, are placed on filter paper in a petri dish on a layer of artificial nutrient. 0.8 ml of the test solution is then pipetted onto the filter paper. Evaluation is made 6 days later. The percentage reduction in population (% activity) is determined by comparing the number of dead eggs and larvae on treated plants with that on untreated plants.
Compounds P.1 to P.11 and of Tables 1 to 3 exhibit good activity in this test. In particular, compounds P.1, P.2, P.3 and P.7 are more than 80 % effective.
Example B4: Action against Plutelia xylostella caterpillars
Young cabbage plants are sprayed with an aqueous emulsion spray mixture comprising 12.5 ppm of test compound. After the spray-coating has dried, the cabbage plants are populated with 10 caterpillars of Plutella xylostella in the first stage and placed in a plastics container. Evaluation is made 3 days later. The percentage reduction in population and the percentage reduction in feeding damage (% activity) are determined by comparing the number of dead caterpillars and the feeding damage on the treated plants with that on the untreated plants,
Compounds P.1 to P.11 and of Tables 1 to 3 exhibit good activity in this test. In particular, compounds P.1, P.2, P.3 and P.7 are more than 80 % effective.
Example BS: Action against Diabrotica balteata
Maize seedlings are sprayed with an aqueous emulsion spray mixture comprising 12.5 ppm of the test compound and, after the spray-coating has dried, the maize seedlings are popu- lated with 10 Diabrotica balteata larvae in the second stage and then placed in a plastics container. 6 days later, the percentage reduction in population (% activity) is determined by comparing the number of dead larvae on the treated plants with that on untreated plants.
Compounds P.1 to P.11 and of Tables 1 to 3 exhibit good activity in this test. In particular, compounds P.1, P.2, P.3 and P.7 are more than 80 % effective. oo
Example B6: Action against Tetranychus urticae
Young bean plants are populated with a mixed population of Tetranychus urticae and sprayed one day later with an aqueous emulsion spray mixture comprising 12.5 ppm of test compound. The plants are incubated for 6 days at 25°C and subsequently evaluated. The percentage reduction in population (% activity) is determined by comparing the number of dead eggs, larvae and adults on the treated plants with that on untreated plants.
Compounds P.1 to P.11 and of Tables 1 to 3 exhibit good activity in this test. In particular, compounds P.1, P.2, P.3 and P.7 are more than 80 % effective.
Claims (8)
1. A compound of formula R2 _ R—N Q \ _o o=} 0) 0 lo} ee o” "o,, 23 eo} “0.,, x o 25 0” “Rt (1) Os 0 x on: 0} OH wherein the bond marked by w~— indicates the S- as well as the R-isomer at the 4"-position; and wherein Ry; is Cy-Cyaalkyl, C3-Cgeycloalkyl; or Cz-Cyoalkenyl;
R. is hydrogen, unsubstituted or mono- to penta-substituted C,-Cy,alkyl or unsub- stituted or mono- to penta-substituted C2-Ci2alkenyl; unsubstituted or mono- to penta-sub- stituted C,-Cyzalkynyl; -C(O)R, or SO,R; Rs is hydrogen, C;-Cizalkyl, mono- to penta-substituted C,-Cy,alkyl, unsubstituted or mono- to penta-substituted C,-C,.cycloalkyl, unsubstituted or mono- to penta-substituted C2-Cyzalkenyl; or unsubstituted or mono- to penta-substituted C»-C4 2alkynyl; or
R. and Rj together are a three- to seven-membered alkylene bridge or a four- to seven-membered alkenylene bridge wherein one CH, group in the alkylene or alkenylene may have been replaced by O, S or NRs; or are a group =N*=N", : and wherein the substituents of the alkyl, alkenyl, alkynyl, alkylene, alkenylene and cycloalkyl radicals defined under R, and R; are selected from the group consisting of OH, halogen, halo-C;-Csalkyl, CN, NO,, C,-Csalkynyl; Cs-Cgeycloalkyl unsubstituted or substituted : by from one to three methyl groups, norbornylenyl; Cs-Cgcycloalkenyl unsubstituted or substituted by from one to three methyl groups; Cs-Cghalocycloalkyl, C,-Cizalkoxy, C4-Cs- alkoxy-C4-Cealkyl, C4-Csalkoxy-C,-Cesalkoxy-Cq-Csalkyl, Cs-Cgeycloalkoxy, C,-Cyzhaloalkoxy, Cy-Craalkylthio, Cs-Cgeycloalkylthio, Cy-Cyzhaloalkylthio, C,-Cioalkylsulfinyl, Cs-Cgeycloalkyl-
sulfinyl, C4-Cyzhaloalkyisulfinyl, Cs-Cghalocycloalkylsulfinyl, C4-Cyalkylsulfonyl, Cs-Cgeyclo- alkylsulfonyl, C4-Cyzhaloalkylsulfonyl, C3-Cghalocycloalkylsulfonyl, C.-Cgalkenyl, C,-Cgalkynyl, NH(C;-Cgalkyl), N(C4-Cgalkyl),, -C(=0)R4, -NHC(=0)R;, -P(=0)(OC,-Cgalkyl); aryl, heterocyclyl, aryloxy, heterocyclyloxy; aryl, heterocyclyl, aryloxy, heterocyclyloxy that, depending upon the possibilities of substitution at the ring, are mono- to penta-substituted by substituents selected from the group consisting of OH; halogen, CN, NOS, Cy-Croalkyl,
Cy Caeydoalkyl, Co-Cyzhaloalkyl, Ci-Cizalkoxy, Cs-Cizhaloalkoxy, Cy-Cizalkyithio, C,-Cyshalo- alkylthio, C,-Csalkoxy-C4-Cealkyl, dimethylamino-C;-Cgalkoxy, C,-Cealkenyl, Co-Cgalkynyl, phenoxy, phenyl-C,-Cealkyl; phenoxy unsubstituted or substituted by from one to three substituents selected independently of one another from halogen, methoxy, trifluoromethyl and trifluoromethoxy; phenyl-C;-Csalkoxy unsubstituted or substituted in the aromatic ring by from one to three substituents selected independently of one another from halogen, methoxy, trifluoromethyl and trifluoromethoxy; phenyl-C,-Csalkenyl, phenyl-C,-Cgalkynyl, methylenedioxy, -C(=0)R,, -O-C(=0)R7, -NH-C(=0)R;, NHz, NH(C;-C alkyl), N(C,-Cyzalkyl)z, C4-Cesalkylsulfinyl, Cs-Cgeycloalkylsulfinyl, C1-Cghaloalkylsulfinyl, Cs-Cghalo- cycloalkylsulfinyl, C,-Csalkylsulfonyl, C3-Cgcycloalkylsulfonyl, C4-Cghaloalkylsulfonyl and Cs-Cghalocycloalkylsuifonyl;
R, is H, OH, C;-Cgalkyl, C;-Cgalkyl mono- to hepta-substituted by halogen, nitro, C4-Csalkoxy, OH, SH, NH,, NH(C;-C1zalkyl) or N(C4-Cyzalkyl),; Ci-Cealkoxy, halo-C1-Cg- alkoxy, Cs-Cgcycloalkyl, Cs-Cgeycloalkoxy, Co-Cgalkenyl, Co-Cgalkenyloxy, C,-Cgalkynyl, C,-Cgalkynyloxy, NH,, NH(C,-Cizalkyl), N(C+-Ci.alkyl),, aryl, aryloxy, benzyl, benzyloxy, heterocyclyl, heterocyclyloxy, heterocyclylmethyl or heterocyclylmethoxy; wherein the radi- cals aryl, aryloxy, benzyl, benzyloxy, heterocyclyl, heterocyclyloxy, heterocyclylmethyl and heterocyclylmethoxy are unsubstituted or, depending upon the possibilities of substitution at the ring, are substituted by from one to.thees substituents SeIGETed independently of one another from halogen, C;-Cyzalkyl, C;-Cyzhaloalkyl, C4-Cyzalkoxy, C;-Cyhaloalkoxy, Cq-Cealk- oxy-C4-Cgalkoxy, C4-Cyzalkylthio, C4-Cyzhaloalkylthio, Co-Cealkenyloxy, Co-Cgalkynyloxy, nitro and cyano;
Rs is Cy-Cgalkyl, C3-Cgcycloalkyl, Co-Cgalkenyl, Co-Cgalkynyl, benzyl or -C(=0)-Rs;
Re is H, OH, SH, NH,, NH(C;-C,alkyl), N(C4-Cyaalkyl),, Ci-Cyaalkyl, C4-Cyzhaloalkyl, C4-Cyqalkoxy, Cy-Cyzhaloalkoxy, C4-Cealkoxy-Cq-Cealkoxy, Ci-Craalkylthio, C,-Csalkenyloxy, C,-Cgalkynyloxy; phenyl, phenoxy, benzyloxy, NH-phenyl, N(C;-Cealkyl)-phenyl, NH-C4-Ce- alkyl-C(=0)-Rs, N(C;-Cgalkyl)-C;-Cgalkyl-C(=0)-Rs; or phenyl, phenoxy, benzyloxy,
WO.03053088 : PCT/EP02/14671 I SE NH-phenyl or N(C;-Csalkyl)—phenyl each of which is substituted in the aromatic ring by from one to three substituents selected independently of one another from halogen, C;-Csalkoxy, C;-Cghaloalkyl and C,-Cshaloalkoxy; Ry; is H, Cy-Caalkyl, Ci-Cyzhaloalkyl, C,-Cgalkenyl, C2-Cgalkynyl, phenyl, benzyl, NH,, NH(C4-Cyzalkyl), N(C4-Croalkyl),, NH-phenyl or N(C;-C;qalkyl)-phenyl; and Rs is H, OH, C4-Cyzalkyl, Cs-Cyzalkoxy, Cy-Csalkoxy-C;-Csalkoxy, C,-Cgalkenyloxy, phenyl, phenoxy, benzyloxy, NH,, NH(C;-Cizalkyl), N(C4-Cyzalkyl)., NH-phenyl or N(C4-Cizalkyl)-phenyi; or, where applicable, an E/Z isomer, a mixture of E/Z isomers and/or a tautomer, in each case in free form or in salt form. .
2. A pesticidal composition comprising as active ingredient at least one compound of formula (1) as described in claim 1, and at least one adjuvant.
3. A method of controlling pests, which comprises applying a composition as described in claim 2 to the pests or to the locus thereof. :
4. A process for the preparation of a composition comprising at least one adjuvant, as described in claim 2, which comprises intimately mixing and/or grinding the active ingredient with the adjuvant(s).
5. Use of a compound of formula (1) as described in claim 1 in the preparation of a composition as described in claim 2.
6. Use of a composition as described in claim 2 in controlling pests.
7. A method according to claim 3 for the protection of plant propagation material, which comprises treating the propagation material or the planting site of the propagation material.
8. Plant propagation material treated in accordance with the method described in claim 7.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH23632001 | 2001-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200404310B true ZA200404310B (en) | 2005-04-07 |
Family
ID=34812842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200404310A ZA200404310B (en) | 2001-12-21 | 2004-06-01 | Avermectin B1 derivatives having an aminosulfonyloxy substituent in the 4"-position. |
Country Status (1)
Country | Link |
---|---|
ZA (1) | ZA200404310B (en) |
-
2004
- 2004-06-01 ZA ZA200404310A patent/ZA200404310B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1456218B1 (en) | Avermectin b1 derivatives having an aminosulfonyloxy substituent in the 4''-position | |
US7678773B2 (en) | Salts of avermectins substituted in the 4″-position and having pesticidal properties | |
US7732416B2 (en) | Avermectins substituted in the 4″-position having pesticidal properties | |
EP1592699B1 (en) | Avermectin and avermectin monosaccharide derivatives substituted in the 4''- or 4'-position having pesticidal properties | |
AU2002254909A1 (en) | Salts of avermectins substituted in the 4"-position and having pesticidal properties | |
AU2002257588A1 (en) | Avermectins substituted in the 4"-position having pesticidal properties | |
EP1501849B1 (en) | 4"-deoxy-4"-(s)-amido avermectin derivatives | |
JP4908213B2 (en) | Evermectin and evermectin monosaccharide substituted at the 4'- and 4 "-positions with insecticidal properties | |
ZA200404310B (en) | Avermectin B1 derivatives having an aminosulfonyloxy substituent in the 4"-position. |